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Our laboratory identified Adiporedoxin (Adrx), an endoplasmic reticulum 
localized oxidoreductase whose expression in adipose tissue is many fold greater 
than other tissues. In gain and loss of function experiments in cultured adipocytes 
Adrx knock down decreased the secretion of numerous adipokines, extracellular 
matrix, and transmembrane proteins and over expression increased secretion. 
Together, these results suggest Adrx regulates an early step in protein secretion 
from the ER. Immunofluorescence and proteolytic protection assays 
demonstrated that Adrx is located in the ER membrane with an ER luminal active 
site. We demonstrated that Adrx regulated protein secretion by affecting the 
oxidation state of ER redox chaperones. Using a cysteine-modifying PEGylation 
reagent, we showed Adrx oscillated between a reduced and oxidized form 
through the -CxxC- active site residues in response to the redox environment of 
the ER. Consequently, knocking down Adrx impaired the re-oxidation of protein 
disulfide isomerase, indicating an overlapping function with known regulators of 
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ER redox homeostasis, namely endoplasmic reticulum oxidoreductase 1a, and 
peroxiredoxin 4. Adrx is oxidized within the ER after treatment with hydrogen 
peroxide (H2O2) and can reduce H2O2 in vitro, suggesting it also acts as an 
antioxidant. The overexpression of Adrx in adipocytes protected the ER from 
oxidative stress and rescued adipokine secretion. Pancreatic islets are also 
highly secretory Adrx is expressed in isolated murine islets. In cultured islet cells, 
Adrx expression also decreased oxidative stress and correlated with the 
secretion of insulin, the main regulator of glucose homeostasis.  
In summary, Adrx expression controls secreted proteins and here we 
describe its ability to regulate the formation and release of disulfide-bonded 
proteins by reoxidizing ER chaperones and alleviating oxidative stress. Secreted 
proteins affect many aspects of metabolism including the control of appetite, 
glucose homeostasis, inflammation, and adipose tissue fibrosis. Overall, these 
data suggest that by mediating secreted proteins Adrx functions as important 
regulator of overall metabolism. 
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CHAPTER ONE 
 GENERAL INTRODUCTION: 
 
In the United States, and most of the western world, obesity and the 
metabolic syndrome have swiftly become all too common. Seventy percent of 
American adults are overweight or obese, a strong majority, with 40% considered 
obese (Ogden et al., 2014).  While some obese individuals are metabolically 
healthy, in most cases obesity is the main contributing factor to the metabolic 
syndrome. The metabolic syndrome is not a disease itself, but the presence of 
multiple metabolic risk factors in the same patient, which lead to an increased 
risk of type 2 diabetes, cardiovascular disease, fatty liver disease, respiratory 
disease, cancer, and an increase in all-cause mortality (Bonomini et al., 2015). 
To underscore the gravity and impact of obesity and the metabolic syndrome, in 
2013 cardiovascular disease was the leading cause of death in the United States 
and diabetes was the 7th (Kochanek et al., 2014).   
 The metabolic syndrome is a collection of risk factors representing 
dysfunction of the many tissues and systems, which define whole body 
metabolism. Adipose tissue, liver, muscle, pancreas, the immune system, and 
brain all contribute to metabolic regulation and dysfunction in any of these results 
in impaired metabolic function.  The cooperation between metabolic tissues is 
perhaps best exemplified by the system of insulin mediate glucose uptake. 
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Insulin is synthesized and released from the pancreas in response to high 
glucose (typically after a meal) as a systemic signal of nutrient availability (Seino 
et al., 2011).  Insulin binds to its cell surface receptor in adipose tissue and 
muscle and initiates a signaling cascade leading to the mobilization of cellular 
glucose transporters such that they mediate absorption of circulating glucose 
(Huang and Czech, 2007). The result of this complicated multi-tissue cooperation 
is tightly regulated whole body glucose homeostasis. Extended periods of 
hyperglycemia as seen in diabetes can have severe consequences, leading to 
blindness, kidney failure, and limb ischemia (Clark, 1994).  Hyperglycemia and 
diabetes can result from dysregulation at either end of this pathway - low insulin 
secretion from the pancreas or insulin resistance in adipocytes, muscles, or liver. 
 Adipose tissue and the pancreas are crucially important to metabolic 
homeostasis because they secrete endocrine factors that regulate all other 
tissues and systems. Insulin and glucagon are secreted from the pancreas and 
directly control the clearance or mobilization of glucose, respectively (Fussganger 
et al., 1969). Adipocytes also play an important role in systemic metabolic 
regulation.  This is achieved through the secretion of various proteins, often 
referred to as ‘adipokines’, that possess both autocrine and paracrine action 
(Galic et al., 2010).  Among their many roles, adipokines and other adipocyte 
secreted cytokines mediate insulin sensitivity, appetite, cardiac function, and 
inflammation (Galic et al., 2010). 
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ADIPOSE TISSUE 
 
Adipocyte Biology 
 
Adipose tissue, comprised of multiple depots is the main site and regulator 
of energy stores, and it is no surprise that dysfunction here is a major contributor 
to the metabolic syndrome (Frayn et al., 2003). Enzymes for lipolysis and 
triglyceride synthesis are tightly coupled with extracellular signaling pathways, 
enabling adipocytes to respond to nutrient availability.  Adipocytes have many 
functions, including their capacity and mechanism for mass lipid storage and 
lipolysis, insulin mediated glucose metabolism, and robust protein secretion. The 
secretion of adipokines and extracellular matrix proteins is of particular 
importance to metabolic regulation (Chakrabarti et al., 2013; Lee and Fried, 
2009; Wang et al., 2006). 
Endocrine Function of Adipocytes: Adipokines   
 Leptin was the first adipokine identified and defined adipose tissue as a 
tightly regulated and influential endocrine organ (Zhang et al., 1994). The 
hormone was discovered through two mouse models, ob/ob and db/db, which 
demonstrated identical phenotypes of marked obesity and hyperphagia on 
C57Bl/6 background, despite harboring different genetic mutations (Coleman and 
Hummel, 1973; Hummel et al., 1972).  A series of parabiosis experiments in 
which ob/ob and db/db mice were surgically joined through shared circulation to 
normal mice or each other revealed db/db produce, but do not respond to, a 
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satiating circulating factor so potent that the partner mouse gradually starved to 
death (Coleman, 1973; Coleman and Hummel, 1969). Ob/ob mice, which 
respond to this circulating factor, starve when fused to db/db mice, but also show 
reduce appetite to normal levels when paired with wild type mice (Coleman, 
1973). Together these experiments revealed a hormone and receptor pair that 
work together to regulate appetite. Db/db overproduce the satiety hormone 
because they lack the receptor. Ob/ob mice have the receptor but cannot 
produce the hormone. In both cases there is no signaling of satiety, which results 
in hyperphagia so intense it leads to obesity. The circulating hormone was 
eventually cloned by Jeff Friedman and colleagues and named leptin, from the 
Greek, leptos (thin) (Zhang et al., 1994). 
   Leptin is a true hormone and acts predominantly on the brain to control 
global energy balance (Bluher and Mantzoros, 2015).  Circulating leptin 
correlates with overall adipose mass but also fluctuates in response to nutritional 
status, increasing sharply during feeding (Barzel et al., 2014).  This increased 
circulating leptin binds to the leptin receptor in the hypothalamus to suppress 
orexigenic peptides and increase anorexigenic peptides, inhibiting appetite 
(Golden et al., 1997).  Originally considered a promising anti-obesity therapy, 
leptin therapy is successful in restoring normal appetite and weight in patients 
homozygous and heterozygous for mutations in leptin (similar to the ob/ob mouse 
model) (Cusin et al., 1996). However, the overall increase in leptin with greater 
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adiposity leads to ‘leptin resistance’ and a decrease in signal sensitivity during 
obesity (Becker et al., 1995; Cusin et al., 1996).  Outside of its action on the 
hypothalamus, leptin also improves insulin signaling, lipid oxidation, and lipid 
accumulation in peripheral tissues (Ahima, 2008).  
Adiponectin is another important adipokine, mostly known for its role in 
enhancing insulin sensitivity (Berg et al., 2001).  Unlike leptin, adiponectin levels 
decrease with obesity and in the metabolic syndrome, typically correlated with 
the decline in insulin sensitivity (Bluher and Mantzoros, 2015; Galic et al., 2010). 
Adiponectin is translated as a monomer but undergoes posttranslational 
modifications and oxidative folding in the ER to form trimers, hexamers, and 
higher molecular weight oligomers (Tsao, 2014; Tsao et al., 2003).  The 
monomer consists an N-terminal collagenous domain, a C-terminal globular 
domain similar to collagens VIII and X and complement factor C1q, and a 
cysteine at position 39. The collagenous and globular domains are partially 
responsible for the generation of high molecular weight forms, but disulfide bonds 
are required for the formation of the trimer and hexamer.  With only a single 
cysteine, one disulfide bond is formed between two subunits within a trimer, with 
the sulfhydryl contributed by the third subunit bonding with the remaining free 
sulfhydryl from another trimer, leading to the formation of a hexamer (Pajvani et 
al., 2003; Tsao et al., 2003). Only secreted in trimer, hexamer, and greater 
multimer forms, serum adiponectin, especially the highest molecular weight form, 
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significantly increases overall insulin sensitivity and plays an important role in 
energy homeostasis and inflammation (Lee et al., 2012b; Wang et al., 2014b). 
Increases in in circulating adiponectin have been shown to lower hepatic glucose 
production, increase fatty acid oxidation in muscle, cause weight loss in mice, 
and be anti-atherogenic (Berg et al., 2001; Fruebis et al., 2001; Yamauchi et al., 
2001). 
Adipsin, or complement factor D, is involved in alternate complement 
pathway activation, but is highly enriched in adipocytes and plays an important 
role in metabolic regulation (Cook et al., 1987).  Similarly to adiponectin, adipsin 
is one of the most abundant proteins in adipocytes but declines during obesity 
and the metabolic syndrome (Cook et al., 1987; Flier et al., 1987).  The adipsinnull 
mouse model has decreased adipose tissue inflammation due to disruption of the 
complement pathway but this positive phenotype is overshadowed by a 
significant exacerbation of diabetic symptoms, specifically hypoinsulinemia. C3a, 
a downstream product of adipsin activity may be necessary for normal glucose 
stimulated insulin secretion (Lo et al., 2014). 
Two other potentially important adipokines are Fibroblast Growth Factor 
21 (FGF-21) and Retinal Binding Protein-4 (RBP4). FGF21, secreted by mouse 
adipocytes and hepatocytes and upregulated in obese patients, increases  insulin 
stimulated glucose uptake and thermogenesis (Kharitonenkov et al., 2005). 
RBP4, at least in rodents, impairs insulin signaling in adipose and muscle tissue 
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and increases glucose production in the liver, contributing to overall insulin 
resistance (Yang et al., 2005).  
While those proteins listed above are the most studied adipokines, many 
other adipose tissue secreted proteins – up to 600 in some estimates – have 
been identified (Lehr et al., 2012).  While many are associated with positive 
metabolic outcomes (i.e. insulin sensitivity), others correlate with insulin 
resistance (Smith et al., 2003). These diverse effects are a demonstration of both 
the scope of adipocyte influence, and the complexity involved in metabolic 
homeostasis. Adipokines are differentially regulated from transcription through 
vesicular trafficking, secretion, and degradation, and different nutrient or stress 
conditions produce unique adipokine patterns and biomarkers (Galic et al., 2010). 
However, there is one regulatory step that unifies the majority of adipokines – 
oxidative folding in the ER.  While adipokines range in size and composition, 
many require inter- or intramolecular disulfide bonds for proper assembly and 
function. The presence of these disulfides are believed to stabilize secreted and 
transmembrane proteins when exposed to the extracellular milieu, and oxidative 
environment, or recycled through endocytic vesicles (Braakman and Bulleid, 
2011).  
Inflammatory cytokines 
 
 Aside from adipocytes, immune cells such as macrophages and T cells 
may play a major role in the health of adipose tissue and disease (Wiedemann et 
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al., 2013).  During obesity, macrophages infiltrate adipose tissue and form crown-
like structures around individual adipocytes (Cinti et al., 2005). This is linked to 
systemic inflammation and insulin resistance (Cinti et al., 2005; Weisberg et al., 
2003).  Inflammatory cytokines produced by both adipocytes and immune cells 
may be responsible for recruiting macrophages and initiating signaling pathways, 
which further compromise adipocyte function and damage cells (Christiansen et 
al., 2005; Wang et al., 2014b). Many of these cytokines are also dependent on 
disulfide bond formation for proper assembly and function, including Tumor 
Necrosis Factor-alpha (TNFa), and Interleukin-6 (IL-6), among others (Narachi et 
al., 1987; Rock et al., 1994).  
Secretory Function of Adipocytes-the Extracellular Matrix 
 
Under conditions of overnutrition, the ability of adipose tissue to expand 
and remodel during weight gain is crucial to the maintenance of overall metabolic 
homeostasis (Sun et al., 2011a). Adipose tissue expands either by hypertrophy, 
increasing cell size, or hyperplasia, increasing cell number, with obesity often 
associated with hypertrophy (Arner et al., 2010). Adipocyte enlargement is often 
accompanied by an increase in adipose tissue fibrosis (Khan et al., 2009). When 
hypertrophy and fibrosis occur together, the adipocyte can become 
necrotic/hypoxic and may initiate an inflammatory response from the surrounding 
tissue (Cinti et al., 2005).  Thus, the regulated secretion of extracellular matrix 
components is tightly tied to adipose tissue health and function.  
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During obesity, adipocytes show an increase in secreted collagens, which 
“stiffen” the extracellular matrix and inhibit adipocyte hypertrophy and remodeling  
[46]. While all collagens are present in adipocytes, collagen VI is highly enriched 
and contributes directly to metabolic function. The deletion of the ColVIa1 gene in 
adipocytes allows for the uninhibited expansion of adipose tissue and mouse 
lacking colVI in adipocytes show an improvement in markers of the metabolic 
system (Khan et al., 2009).   
With such a large variety of secreted proteins, the adipocyte ER is 
designed to optimize protein translation and export. During adipogenesis the 
upregulation of endoplasmic reticulum (ER) chaperones and stress mediators 
create a mature adipocyte with significantly increased capacity to translate, fold, 
and secrete proteins, adiponectin for example (Long et al., 2010; Qiang et al., 
2007). ER oxidative folding in all cells is a tightly regulated and important 
process, demonstrated by extensive functional overlap and compensation 
between redox proteins (Braakman and Bulleid, 2011). In adipocytes, oxidative 
folding is especially important as a regulatory step because influences the 
majority of secreted proteins equally.  Similar to adipokines, cytokines and 
extracellular matrix proteins often require disulfide bonds for correct assembly 
and function (Long et al., 2010; Qiang et al., 2007). 
PANCREAS  
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Islet Cell Biology 
As stated earlier, dysregulation of the pancreatic hormones insulin and 
glucagon contribute to the metabolic syndrome and subsequent diabetes. 
Diabetes mellitus currently affects 390 million people worldwide and is comprised 
of several metabolic diseases defined by prolonged elevate blood glucose and 
insufficient insulin secretion by the pancreas (Danaei et al., 2011). The endocrine 
activity of the pancreas originates from micro-organs known as Islets of 
Langerhans, which comprise 1-2% of the mass of the pancreas. Islets are 
comprised of 4 types of endocrine cells: α-cells which produce glucagon, β-cells 
which produce insulin and amylin, δ-cells which produce somatostatin, and λ-
cells which produce pancreatic polypeptides (Orci and Unger, 1975). These 
endocrine cells are not randomly arranged, rather, they exist in a conserved 
organized structure with β-cells in the core, and α-, δ-, and λ-cells in the 
periphery adjacent to blood vessels. Alpha- and β-cells are the most abundant 
and also the most important in that they secrete hormones (glucagon and insulin, 
respectively) crucial for glucose homeostasis (Bosco et al., 2010; Orci and 
Unger, 1975). α- and β-cell dysregulation disrupts glucose homeostasis, leading 
to life-threatening hypoglycemia when insulin secretion is excessive and to 
damaging hyperglycemia whenever insulin secretion is insufficient or glucagon is 
over produced. This is particularly important in the context of diabetes, a complex 
condition that has β-cell dysfunction at its core.  
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 Loss of β-cell function and mass from the onset of both type 1 diabetes 
mellitus (T1DM) and type 2 diabetes melitus (T2DM) causes a corresponding 
decrease in overall glycemic control (Butler et al., 2003; Weir et al., 2001). In 
T1DM an autoimmune attack of auto reactive T cells destroys β-cells and 
patients require lifelong treatment with exogenous insulin (Gepts, 1965). The 
pathogenesis is more complex in T2DM; loss in β-cells function and mass and 
subsequent decreased insulin secretion, occur concurrently with different 
degrees of systemic insulin resistance (Butler et al., 2003; Weir et al., 2001).  
Insulin Secretion 
 
The appropriate release of insulin is a crucial function of pancreatic β-
cells. Therefore it is under it is under tight control by an array or stimulatory and 
inhibitory factors, the most prominent stimulus being glucose. During high 
glucose insulin is needed to signal the uptake of excess glucose by GLUT4 in 
muscle and adipose tissues, however circulating insulin during normal or low 
glucose can cause hypoglycemia (Seino et al., 2011). Pancreatic beta cells utilize 
glucose transporter 2 (GLUT2) to take up glucose from the circulation. GLUT2 
has a high capacity for glucose but a low affinity with Km of 15 – 20 mM. With a 
high Km and capacity, GLUT2 acts as a glucose sensor and glucose is taken up 
rapidly only when it is abundant (typically after a meal) (Henquin, 2004).   When 
extracellular glucose reaches a stimulatory threshold, glucose metabolism within 
the β-cells produces sufficient ATP to close KATP channels and depolarizes the 
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plasma membrane (Seino et al., 2011). The depolarization causes voltage gated 
Ca2+ channels to open and a subsequent influx of Ca2+ into the cytoplasm 
(Henquin, 2009). Calcium influx is a crucial step in stimulated insulin secretion, 
as it regulates the exocytosis of insulin granules. Elevated Ca2+ is required for 
multiple steps in the exocytosis process, including activation of Ca2+-activated 
phosphatase, as ligand for Ca2+-binding proteins such as calmodulin and 
synaptotagmins, calmodulin-dependent protein kinase and Ca2+-activated 
phosphatases, and the fusion of the granule with the plasma membrane 
(Gauthier and Wollheim, 2008; Henquin, 2004, 2009). The triggering affect of 
Ca2+ is so essential that all agents that impair rising Ca2+ completely inhibit the 
stimulatory effect of glucose, and experimental conditions causing an isolated 
rise in Ca2+ stimulate insulin secretion independent of glucose metabolism 
(Gembal et al., 1992; Henquin, 2004).  
Independent of stimulated exocytosis, insulin secretion is also dependent 
on proper folding and cleavage of its precursor preproinsulin (Guo and Feng, 
2001). The insulin gene is translated as a one long single chain preproinsulin 
peptide that first undergoes cleavage of its signal peptide to form proinsulin (Liu 
et al., 2012). Proinsulin is further processed in the ER by the formation of 3 
disulfide bonds - two inter-chain disulfide bonds between the A and B chains, and 
one intra-chain linkage in the A chain. Without properly formed inter-chain 
disulfides insulin secretion is severely impaired and the correct formation of all 
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three disulfides is essential for the receptor binding activity (Chang et al., 2003; 
Guo and Feng, 2001). Proinsulin is trafficked and stored in beta granules which 
contain a proteolytic enzyme to cleave and remove the C-peptide leaving mature 
insulin for exocytosis (Sizonenko and Halban, 1991). 
DISULFIDE BOND FORMATION 
Oxidative protein folding  
 
 Proteins targeted for the secretory pathway are first recognized by an N-
terminal signal sequence which directs the ribosome from the cytosol to the ER. 
After the remaining polypeptides are translated into the ER, secreted proteins 
undergo multiple modifications including glycosylation and the formation of 
disulfide bonds, as they are trafficked through the ER, golgi, and other trafficking 
vesicles (Dacks and Field, 2007). 
 As mentioned, many crucially important metabolic hormones from both 
adipocytes and islets require disulfide bonds for bioactivity and even secretion.  
While disulfide bond formation may occur spontaneously, it requires a redox 
reaction and proceeds both slowly and haphazardly without enzymatic 
assistance (Anfinsen et al., 1961).  Because disulfide bonds are especially 
important to the structure and function of secreted proteins, the ER is equipped to 
facilitate their formation through the process of oxidative folding.  In contrast to 
the rest of the cell (except mitochondria), the ER maintains an oxidative 
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environment with a reduced to oxidized glutathione (GSH:GSSG) ratio of 3:1 
(compared to 100:1 in the cytosol), favoring the oxidation of free thiols (Hwang et 
al., 1992).  This is sustained by a complex electron relay system comprised of 
protein disulfide isomerases (PDIs) protein chaperones, ER oxidoreductases, 
and peroxiredoxins, which transfers electrons from newly translated proteins 
(reduced cysteines) to oxygen or hydrogen peroxide. When a protein with 
reduced cysteines (-SH) donates electrons to a redox chaperone those cysteines 
become oxidized (-S-S-), and a covalent, disulfide bond is formed between the 
sulfhydryl groups (Figure 1.1).  
Protein Disulfide Isomerase (PDIs) Chaperones 
 
 PDIs are members of the Thioredoxin family and specifically catalyze thiol-
disulfide oxidation, reduction and isomerization in the ER (Sato et al., 2013).  
Newly translated proteins form mixed disulfide bonds with oxidized thioredoxin 
chaperones including PDIs, and the termination of this reaction transfers the 
disulfide bond from the chaperone to the protein, leaving the chaperone in the 
reduced state.  The first PDI was named in 1973 and since then more than 20 
have been identified in higher eukaryotes, emphasizing the complexity and 
importance of correct protein assembly (Appenzeller-Herzog and Ellgaard, 2008; 
Hawkins and Freedman, 1975).  Recent studies indicate that not all PDIs are 
equivalent in function or kinetics, each having unique substrate preference for 
either Endoplasmic reticulum oxidoreductase-1 alpha (Ero1a) or Peroxiredoxin4 
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(Prdx4) (Sato et al., 2013).  Additionally, PDIs act on translated proteins at 
different stages of oxidation. The PDIs, ERp46 and P5, act quickly on reduced 
proteins with little specificity, sometimes resulting in non-native disulfide bonds.  
This is corrected by another PDI, which proofreads oxidized proteins, isomerizing 
incorrectly formed disulfide bonds to their proper orientation. This cooperative 
action accelerates the assembly and secretion of native proteins (Sato et al., 
2013). 
End terminal electron donors 
 
PDI chaperones are re-oxidized by either ER oxidoreductases, Ero1 or  
peroxiredoxin 4 (Prdx4), which donate electrons to either molecular oxygen or 
hydrogen peroxide, respectively, to form initial disulfide bonds enabling overall 
oxidative folding (Appenzeller-Herzog and Ellgaard, 2008; Hatahet and Ruddock, 
2009; Sato et al., 2013; Zito et al., 2010b).  It was once believed that Ero1alpha, 
which catalyzes a disulfide bond in concert with flavin adenine dinucleotide 
(FAD), served as the primary oxidase of PDIs. However, the discovery of Prdx4 
has changed our understanding of this pathway (Araki and Inaba, 2012; Zito et 
al., 2010b).  Prdx4 can recycle hydrogen peroxide, the by-product of Ero1α 
oxidation, but one also produced by other sources, for the same purpose, 
buffering ER redox homeostasis.  The importance of disulfide bond formation 
necessitates overlap in this pathway as demonstrated by the lack of phenotype in 
Ero1α knockout mice (Zito et al., 2010a).  Highly secretory cells such as beta 
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cells and immunoglobulin secreting cells are especially dependent on proper 
oxidative folding and express another form of Ero1, Ero1b (Zito et al., 2010a). 
THIOREDOXIN FOLD 
 
Thioredoxin fold family 
 
 PDIs and end terminal electron donors all belong to the thioredoxin fold 
class (Atkinson and Babbitt, 2009; Pan and Bardwell, 2006; Whitbread et al., 
2005). The thioredoxin fold class is a large and diverse group of protein 
superfamilies defined by the presence of a thioredoxin domain comprised of 3 
alpha helices surrounding 4 beta sheets and in many cases, a dithiol catalytic 
site (Pan and Bardwell, 2006).  This basic structure creates a redox active pocket 
enabling proteins to participate in the reduction or oxidation of disulfide bonds.  
Small structural variations on the thioredoxin fold allow for great flexibility of 
substrates between the superfamilies and despite similar classification, 
thioredoxin proteins have a variety of functions ranging from protein folding to the 
detoxification of exogenous and endogenous compounds With the exception of a 
few enzymes with very specific roles, copper binding by cytochrome C oxidase, 
glutathione chemistry by glutathione S-transferase (GST), and the reduction of 
arsenate by arsenate reductase, most thioredoxin fold proteins act as 
antioxidants or participate in protein-protein redox reactions (Atkinson and 
Babbitt, 2009).   
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Oxidation and Reduction of Proteins 
 
 As mentioned earlier, a main function of thioredoxin fold proteins in the 
reduction and formation of disulfide bonds in other proteins. In the oxidizing 
environment of the ER, thioredoxins participate in oxidative folding, covered 
earlier in this introduction.  In the cytoplasm, various reductive enzymes including 
ribonucleotide reductase, methionine sulfoxide reductase, and 3′-
phosphoadenosine 5′-phosphosulfate reductase become oxidized as part of their 
catalytic cycle and must be reduced for continued function.  This is accomplished 
by thioredoxins and glutaredoxins (Aslund and Beckwith, 1999).  
Thioredoxins (Trx) utilize the two cysteine residues in a CxxC active site to 
reduce target protein disulfides. The new disulfide in the active site of Trx is then 
reduced by the dimeric flavo-enzyme thioredoxin reductase at the expense of 
NADPH. Glutaredoxins (Grxs) have overlapping targets with Trx but are 
maintained in the reduced form by glutathione (GSH) and also act to reduced 
protein-GSH mixed disulfides (de-glutathionylation) (Berndt et al., 2008). 
Antioxidants 
 
 Hyperoxides or Reactive Oxygen Species (ROS) are a natural byproduct 
of metabolic processes and have an important role in signaling and cell 
homeostasis.  Unregulated ROS quickly generates oxidative stress, and excess 
free radicals damage nucleic acids, proteins, and lipids, eventually leading to cell 
death (Ray et al., 2012).  Several groups of thioredoxin proteins act as 
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antioxidants within different cellular compartments to maintain this delicate redox 
balance. Peroxiredoxins are protective antioxidants and rapidly detoxify hydrogen 
peroxide (H2O2), organic hydroperoxides (ROOH), and peroxynitrite (OONO-).  Of 
the 6 mammalian peroxiredoxin (Prx) family members, Prx1, 2, and 4 are found 
in cytosol and act as ROS scavengers, protein chaperones and signaling 
molecules (Jarvis et al., 2012).  ER resident Prdx4 participates in oxidative 
folding through the generation of disulfide bonds by reducing H2O2, balancing the 
redox state in the ER and PrxIII is responsible for the reductions of up to 90% of 
H2O2 generated in the mitochondria (Cox et al., 2010; Zito et al., 2010b).   
 Glutathione peroxidases (GPX) also reduce hydrogen peroxides and alkyl 
hydroperoxides using glutathione. Mitochondrial and cytosolic glutathione 
peroxidases mainly reduce soluble H2O2 but GPX4, found in the membrane 
fraction, also directly reduces complex lipids including fatty acid and cholesterol 
hydroperoxides (Yoo et al., 2010).   
Thioredoxin Enzymatic Redox Chemistry  
 
All thioredoxin proteins conduct redox reactions through a similar dithiol 
mechanism (Figure 1.2). Thioredoxin fold proteins participate in this exchange on 
either side, both as oxidants (Protein B) or reductants (Protein A) (Holmgren, 
1995).  Oxidants, such as PDI, are typically found in the oxidized form and 
catalyze the transfer of that disulfide bond to substrate proteins while accepting 
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electrons.  Reductants such as Trx, are typically found in the reduced form and 
donate electrons to various substrates while accept disulfide bonds.  
The oxido-reductase function of specific thioredoxin proteins is usually 
inline with the immediate redox environment. The mitochondria, cytosol, and the 
nucleus are the most reducing compartments with redox potential maintained 
below ΔE’0 = -220mV in part due to thioredoxin proteins which act as strong 
reductants (Dardalhon et al., 2012; Jones and Go, 2010).  The ER and 
mitochondrial intermembrane space (IMS) have much higher redox potentials, 
reflected by the strong thioredoxin oxidants present to facilitate protein folding 
(Hwang et al., 1992). 
Characteristics of the thioredoxin fold 
 
  The defining characteristic of thioredoxin proteins is the presence of a 
highly conserved pattern of beta sheets and alpha helices to form the thioredoxin 
fold).  More specifically, the fold can be subdivided into an N-terminal βαβ and a 
C-terminal ββα domain, which are connected by an intermediate α helix to form 
the traditional β1α1β2α2β3β4α3 pattern (Figure 1.3).  Within in the fold, the active 
disulfide/dithiol residue is located at the N-terminal of α1 (Martin, 1995).  Many 
thioredoxin fold proteins contain a dual cysteine (C-x-x-C) active site, but others 
do not. The individual cysteine residues also vary between superfamilies.  
Peroxiredoxins, glutathione peroxidases, Disulfide Interchange Protein DsbA 
(DsbA) proteins, and some others replace one or both of the cysteines with a 
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serine or threonine. Even if the active site includes dual cysteines, at times the 
resolving thiol group is not part of this domain, rather found towards the C-
terminal or another protein and only brought into range of the first cysteine 
through intricate tertiary or quaternary structure (Atkinson and Babbitt, 2009). 
This core structure is conserved across all superfamilies but each has developed 
small structural variations to optimize different functions. 
There are several determinants of redox potential and function that aid in 
the sub classification of thioredoxin fold proteins, these include structural and 
sequential differences in the thioredoxin fold.  Structural variations involve the 
addition of helices or beta sheets to the original redox pocket to fit different 
substrate types.  Sequential differences are less conserved but small mutations 
in the dithiol active site (CxxC domain) and externally exposed cis-pro loop 
strongly influence redox potential and activity (Atkinson and Babbitt, 2009; 
Nathaniel et al., 2003; Pan and Bardwell, 2006; Su et al., 2007). 
OXIDATIVE STRESS 
Reactive Oxygen Species 
 
Thioredoxin fold family proteins utilize ROS for many redox reactions, 
even having antioxidant function as stated above. ROS play paradoxical roles in 
cellular physiology; they are integral signaling molecules but also can cause 
cellular damage and impair protein secretion. Oxidative stress is the deregulation 
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and accumulation of ROS leading to cell damage and death.  ROS include 
superoxide anion (O2–), hydrogen peroxide (H2O2), and hydroxyl radicals (.OH), 
and are byproducts of natural aerobic metabolism.  Mitochondria are the main 
source of ROS, generating superoxide through NADPH oxidase and the one 
electron reduction of molecular oxygen (Poyton et al., 2009; Quinlan et al., 2013).  
Oxidative folding in the ER also contributes to intracellular ROS through the 
transfer of electrons to molecular oxygen to generate disulfide bonds (Sevier and 
Kaiser, 2008).  ROS from both of these sources can act as signaling molecules 
by oxidizing thiolate anions on target proteins to sulfenic form.  This oxidation 
causes allosteric changes in the target protein and alters its function (Roos and 
Messens, 2011).   
In a classic case of “too much of a good thing”, this mechanism, which is 
necessary for signaling, is also the source of oxidative stress.  While the sulfenic 
form can be reduced by thioredoxins, further oxidation to the sulfinic or sulfonic 
forms is irreversible and often results in protein damage (Roos and Messens, 
2011).  Additionally, superoxide generated by NADPH which is not immediately 
converted to H2O2 by superoxide dismutases (SOD1 and 2), can damage and 
inactivate proteins containing iron clusters (Fridovich, 1997).  Hydroxyl radicals, 
produced through the interaction of H2O2 and ferrous ions, are a third source of 
oxidative stress and indiscriminately oxidized lipids, proteins, and DNA, causing 
damage and genomic instability (Dizdaroglu and Jaruga, 2012). 
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Response to Oxidative Stress 
 
 To maintain optimal levels of ROS, all cells are equipped with a variety of 
antioxidants to scavenge and dispose of excess oxidants, both enzymatic and 
nonenzymatic. Nonenzymatic antioxidants are found in both soluble 
compartments and cell membranes and include vitamins C and E, β-carotene, 
and glutathione (Birben et al., 2012). The best characterized enzymatic 
antioxidants are the superoxide dismutases, which convert O2- to H2O2, and 
catalase and glutathione peroxidases, which potently catalyze the reduction of 
H2O2 to water. Additional antioxidants include many thiol containing enzymes - 
peroxiredoxins, glutathione peroxidases, glutaredoxins, thioredoxins, and 
thioredoxin reductases – which both reduce oxidants directly and regenerate 
other antioxidant molecules including ubiquinone, lipoic acid, and afore 
mentioned vitamin C (Birben et al., 2012).  
 Appropriately deploying antioxidants during times of oxidative stress 
requires coupling antioxidant regulation to a ROS sensing mechanism.  For many 
proteins involved in antioxidant detoxification this is accomplished through the 
nuclear factor E2-related factor 2 (Nrf2) antioxidant response element (ARE) 
signaling pathway, found in the promoters of peroxiredoxins and other 
thioredoxin family members (Chowdhury et al., 2009; Favreau and Pickett, 1991; 
Kim et al., 2007b; Rushmore and Pickett, 1990). Activation of gene expression 
through ARE is primarily mediated through Nrf2, a transcription factor which 
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resides in the cytosol and translocates to the nucleus during oxidative stress 
(Nguyen et al., 2005).  Nrf2 activity is regulated through interaction with Kelch-
like ECH-associated protein 1 (Keap1), a cysteine rich protein sensitive to 
disulfide modification during changes in redox homeostasis. During basal 
conditions, Keap1 sequesters Nrf2 in the cytosol and enhances its ubiquination 
and degradation. Oxidative stress triggers conformational changes in Keap1 and 
the dissociation of this complex, allowing Nrf2 to enter the nucleus and bind to 
ARE (Niture et al., 2009; Zhang and Hannink, 2003). 
Changes in oxygen tension, specifically hypoxia, also increase oxidative 
stress and intracellular ROS (Poyton et al., 2009).   Cells sense and respond to 
hypoxia generated oxidative stress through adaptive changes in gene expression 
mediated by transcriptional regulator hypoxia-inducible factor 1 (HIF-1) 
(Semenza, 2000). HIF-1 is composed of α and β subunits and, like Nrf2, is 
constitutively expressed but degraded in the cytosol during normoxia. HIF-1α 
contains an oxygen-dependent degradation domain that, when hydroxylated 
during normoxia, leads to ubiquitinylation and degradation by the 26S 
proteasome. At low oxygen levels HIF-1α stabilizes, translocates to the nucleus, 
and binds to hypoxia-response elements in the promoter of target genes (Bonello 
et al., 2007). HIF1 enhances the transcription of over 100 genes to maintain 
oxygen and energy homeostasis, including metabolic and redox enzymes, and 
glucose transporters (Hayashi et al., 2004; May et al., 2005; Semenza, 2000).  
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Oxidative Stress in the ER  
 
 Oxidative stress in the ER is tightly tied to classical ER stress and the 
unfolded protein response (UPR) through oxidative folding (Schroder and 
Kaufman, 2005).  The UPR is a three-pronged response to the accumulation of 
misfolded proteins and acts to restore ER homeostasis by decreasing protein 
translation and upregulating ER chaperones (Walter and Ron, 2011). Misfolded 
proteins and the UPR increase the activity of Ero1a, generating excess ROS and 
subsequent oxidative stress (Hansen et al., 2012).  Conversely, an increase is 
ROS and hyperoxidation of the ER can cause misappropriated disulfide bonds 
and misfolded proteins, triggering the UPR and an efflux of ER Ca2+ (Bansaghi et 
al., 2014; Li et al., 2009). This integrated relationship creates a challenge to 
researchers but also speaks to the importance of redox homeostasis in the ER. 
GOALS OF THE THESIS 
 
  
We performed a proteomic analysis of Glut4 storage vesicles (GSVs) 
where these were selectively immunoadsorbed with anti-Glut4-coupled beads 
following depletion of Glut4-precursor compartments (Jedrychowski et al., 2010). 
Amongst the proteins we discovered in the GSV-precursor membranes were 
several potential ER residents including one that was known at the time only as a 
possible secreted protein (c10orf58) whose mRNA was expressed in human 
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testes (Clark et al., 2003). We are now calling the protein Adiporedoxin (Adrx) to 
reflect its high expression in adipose tissues and structural thioredoxin fold 
(Jedrychowski et al., 2010). Adrx contains a classic thioredoxin fold structure as 
well as a PDI-like CxxC active site and transmembrane domain (Figure 1.4). Adrx 
was first described as peroxiredoxin (PRX)-like 2 activated in M-CSF 
stimulated monocytes (PAMM) and identified as a redox regulatory protein that 
mediates osteoclast differentiation in vitro, however there have been no follow on 
publications in bone or other tissues (Xu et al., 2010). In adipocytes, Adrx 
expression directly correlates with secreted and transmembrane proteins, 
specifically Adpn, adipsin, and the Insulin receptor, but the mechanism behind 
this relationship was previously unknown.   
 This thesis will address the mechanism of Adrx in three parts. Chapter 
Two will explore whether Adrx is an ER redox protein and what may be its role in 
oxidative protein folding. Chapter Three will answer whether Adrx has an 
antioxidant function and how this affects oxidative stress and protein secretion. 
Lastly, Chapter Four will investigate if Adrx is expressed in islets, another 
secretory tissue, and if Adrx has an effect on insulin secretion. 
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Figure 1.1 “Textbook model” of oxidative folding of secreted proteins. 
Simplified model of oxidative folding – Ero1 generates a de novo disulfide bond 
utilizing molecular oxygen as an electron acceptor. Ero1 transfers the disulfide to 
PDI through redox exchange chemistry. PDI transfers the disulfide to newly 
translated proteins in the ER. 
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Figure 1.2 Disulfide Exchange Chemistry. 
1. Protein A is in the reduced form and Protein B is in the oxidized form. 2. 
Leading cysteine of Protein A is deprotonated forming a thiolate anion which 
displaces one sulfur of the disulfide bond in Protein B. 3. This results in a 
transient mixed disulfide between Protein A and B. 4.The reduced substrate is 
then released via an intramolecular nucleophilic attack of the resolving cysteine 
of Protein A on the sulfur of the leading cysteine that is engaged in the mixed 
disulfide bond. 5. This leaves Protein A in the oxidized form and Protein B in the 
reduced form. 
   
28	
 
 
Figure 1.3 Architecture of the Thioredoxin Fold. 
Thioredoxin fold is a structural motif consisting of a four-stranded β-sheet and 
three flanking α-helices. The motif is divided into an N-terminal βαβ C-terminal 
ββα linked by the third helix. The dithiol reactive site (CxxC) is located on the N-
terminal of the α1 helix. 
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Figure 1.4 Adrx modeled structure reveals a thioredoxin fold. 
Green coils represent predicted α-helix and blue arrows represent predicted β-
sheets. Text notation indicates structural components of Adrx thioredoxin fold. 
Genome 3D Structural Bioinformatics Group. Imperial College, London. (Protein 
structure prediction on the web: a case study using the Phyre server Kelley LA 
and Sternberg MJE. Nature Protocols 4, 363 - 371 (2009))  
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Summary 
 
 We have identified an endoplasmic reticulum-localized thioredoxin family 
member we call adiporedoxin (Adrx) because of its tissue expression profile. 
Adiporedoxin functions via a CXXC active site, and is upstream of protein 
disulfide isomerase whose direct function is disulfide bond formation, and 
ultimately protein secretion. Over and under expression of Adrx in vitro enhances 
and reduces, respectively, the secretion of the disulfide-bonded proteins, 
adiponectin and collagens. On a chow diet, Adrx null mice have normal body 
weights, and glucose tolerance, are moderately hyperinsulinemic, have reduced 
levels of circulating adiponectin and are virtually free of adipocyte fibrosis. Adrx 
mRNA and protein levels in human adipose tissue correlate positively with 
adiponectin mRNA and protein and negatively with the inflammatory marker, 
phospho-Jun kinase. These data support the notion that Adrx plays a critical role 
in adipocyte biology and in the regulation of mouse and human metabolism via its 
modulation of adipocyte protein secretion. 
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Introduction: 
 
 In addition to fat storage and release, white adipose tissue (WAT) makes 
and secretes adipokines, hormone-like polypeptides which act in an endocrine 
and paracrine fashion to affect numerous physiological processes such as 
energy balance and insulin sensitivity (Kadowaki et al., 2011). In addition, fat 
cells in adipose tissue are maintained as an organ by extracellular matrix proteins 
including multiple collagen isoforms whose cellular origin is not completely clear 
(Divoux and Clement, 2011). The initial folding and assembly of all secreted and 
integral membrane proteins, takes place in the endoplasmic reticulum (ER) and is 
mediated by the actions of numerous enzymes and chaperones (Braakman and 
Bulleid, 2011; Gidalevitz et al., 2013; Lu and Holmgren, 2014). About 1/3 of all 
cellular proteins pass through the ER and the vast majority of these have inter- 
and/or intra-molecular disulfide bonds whose formation also takes place in the 
ER mediated by enzymes of the thioredoxin superfamily (Feige and Hendershot, 
2011; Lu and Holmgren, 2014; Oka and Bulleid, 2013). Improper disulfide bond 
formation leads to protein misfolding and potentially, ER stress, which can have 
deleterious consequences for cells, for example, apoptosis in the endocrine 
pancreas due to insulin misfolding (Back and Kaufman, 2012; Tabas and Ron, 
2011). Therefore, while normal ER function is essential in all cells, it is especially 
important in secretory cells such as adipocytes and pancreatic beta cells.  
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 Adiponectin assembly and disulfide bond formation impose a particular 
burden on the adipocyte ER because it circulates at high concentrations, ca. 30 
nM, yet is turned over quite rapidly in blood (Halberg et al., 2009). Adiponectin 
has a complicated tertiary structure with post-translational modifications that 
include the ER-dependent formation of intermolecular disulfide bonds that are 
required for oligomerization into its most physiologically relevant form, an 
octadecamer (the high molecular weight or HMW form) (Briggs et al., 2009; Tsao, 
2014; Tsao et al., 2003) as well as hydroxylation, glycosylation and proline 
isomerization all of which occur in its collagenous domain (Kivirikko and 
Myllyharju, 1998; Liu and Liu, 2010; Wang et al., 2008). Adiponectin must 
therefore be properly and efficiently assembled and secreted at high rates, and 
malfunctions of this process will lead to ER stress in the adipocyte and 
subsequent perturbation of fat cell and organismal metabolism such as insulin 
resistance and type 2 diabetes (Gregor and Hotamisligil, 2007). The assembly 
and secretion of collagens from adipocytes (and other cells) also requires 
disulfide bonds (Kivirikko and Myllyharju, 1998) and excess collagen deposition 
leads to a fibrotic pathology in adipose tissue (Sun et al., 2013). 
 What little is known about disulfide bond formation in the adipocyte ER 
concerns adiponectin assembly which requires the action of the enzyme, 
endoplasmic reticulum oxidoreductase 1a (ERo1a), a primary electron acceptor 
that uses molecular oxygen and a flavin nucleotide to initiate oxidative protein 
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folding (Sevier and Kaiser, 2008). ERo1a does not interact directly with 
substrates such as adipokines to mediate S-S bond formation, rather it oxidizes 
members of the protein disulfide isomerase (PDI) family, which interact with 
substrates and mediate correct disulfide bond formation and protein folding 
(Appenzeller-Herzog and Ellgaard, 2008; Araki et al., 2013; Sevier and Kaiser, 
2008). ERo1a has also been shown to interact with endoplasmic reticulum 
protein, ERp44 to mediate what has been called dynamic ER retention of 
substrates(Otsu et al., 2006). The combined actions of ERo1a and ERp44 have 
been shown to play a role in adiponectin assembly and secretion (Qiang et al., 
2007; Wang et al., 2007). A third PDI relative implicated in adiponectin 
multimerization is the disulfide bond A oxidoreductase-like protein (DsbA-L) (Liu 
et al., 2008). Unlike ERo1a and ERp44, it lacks both active site cysteines 
required for redox function and a classical ER localization signal, but it may 
instead have a chaperone function in protein folding. None of the above proteins 
has a notable tissue-specific distribution although the expression of DsbA-L is 
somewhat higher in adipose than in other tissues examined, and it is induced 
upon differentiation of 3T3-L1 cells (Liu et al., 2008). 
 We performed a proteomic analysis of GLUT4 storage vesicles (GSVs) 
where these were selectively immunoadsorbed with anti-GLUT4-coupled beads 
following depletion of GLUT4-precursor compartments (Jedrychowski et al., 
2010). Amongst the proteins we discovered in the GSV-precursor membranes 
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were several potential ER residents including one that was known at the time 
only as a possible secreted protein (c10orf58) whose mRNA was expressed in 
human testes (Clark et al., 2003). Its sequence revealed a CXXC motif which is 
the active site sequence of an oxidoreductase (Appenzeller-Herzog and Ellgaard, 
2008; Lu and Holmgren, 2014). We determined by qPCR that its mRNA was 
expressed in mouse testes, but we also saw that mRNA expression in brown and 
white fat was an order of magnitude higher than in any other mouse tissue except 
testes (data not shown), which we confirm here for protein expression (Figure 
2.1). Consequently, we are calling this molecule adiporedoxin (Adrx) and we 
show here that it plays an important role in the assembly and secretion of 
disulfide-bond containing proteins, in particular, adiponectin in murine and human 
cells adiponectin and collagens in murine cells. Its absence in mice leads to a 
complex and mixed phenotype of lower adipokine secretion and lower adipocyte 
collagen deposition along with adipocyte ER stress and hyperinsulinemia. 
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Results:  
 
Adiporedoxin (Adrx) is an ER protein highly expressed in white (WAT) and 
brown (BAT) adipose tissue and is induced during adipocyte 
differentiation. 
 Figure 2.1A shows the sequences of mouse and human Adrx with their –
CXXC- active sites (red) and transmembrane (TM) region/leader sequences 
(green underlined), both domains indicated in the cartoon of Figure 2.1B. Figure 
2.1C and 2.1D show respectively, the tissue distribution of Adrx protein in mice 
and the time-dependency of its expression as a function of 3T3-L1 adipocyte 
differentiation. As expected, Adrx protein expression was relatively high in testis, 
and although great care was taken in removing fat from the other tissues, traces 
of Adrx (compared to fat and testes) can be observed in small intestine and 
spleen, which probably reflects low level expression in those tissues (Figure 
2.1C). Like many proteins that are highly expressed in adipocytes, GLUT4 for 
example (Birnbaum, 1989), Adrx was markedly induced as preadipocytes 
differentiate (Figure 2.1D). Like the murine cells, cultured human adipocytes 
express Adrx mRNA and protein in a differentiation dependent fashion and its 
knockdown in these cells results in diminished adiponectin secretion (data not 
shown). Adrx mRNA is also expressed in human adipose tissue to a much 
greater degree than in other human organs (data not shown).  
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 We determined by sucrose gradient fractionation in primary rat adipocytes 
(Figure 2.1E) that Adrx was colocalized with the ER membrane marker, calnexin 
(Cnx) (Bedard et al., 2005), and was well separated from GLUT4-rich vesicles.  
Its partial co-localization with cellugyrin (CG), a marker for diverse intracellular 
vesicles (Kupriyanova and Kandror, 2000), accounts for its appearance in GSV 
precursor membranes that allowed its initial identification (Jedrychowski et al., 
2010). To put Adrx into the context of other possible ER contributors to fat cell 
ER function, disulfide bond formation and protein secretion, we subjected 
membranes from 3T3-L1 adipocytes to sucrose gradients and showed that Adrx 
overlaps significantly with proteins of the ER lumen, namely adiponectin (Adpn), 
ERo1a and PDIa1 (Figure 2.1F). These last three proteins are soluble and were 
partially released from the ER during cell fractionation and therefore migrated at 
the top of the gradient, whereas Adrx did not, confirming its integral membrane 
association. On the other hand, DsbA-L distributed only to the top of the gradient 
indicating it is unlikely to be a resident of the ER lumen. Lastly, we confirmed by 
immunofluorescence microscopy in 3T3-L1 adipocytes, the nearly complete co-
localization of Adrx with calnexin, its partial localization with adiponectin and its 
minimal, if any co-localization with porin (Colombini, 2012), hence mitochondria 
(Figure 2.1G).  
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Adrx levels affect adiponectin and collagen secretion. 
 Given the CXXC motif of adiporedoxin and its ER localization, its role in 
disulfide bond formation and subsequent protein secretion seemed likely. Thus 
we generated Adrx knockdown and overexpressing 3T3-L1 cells (Figure 2.2A) 
and monitored secreted (Figure 2.2 A B) adiponectin and collagen (Figure 2.2C) 
comparing them to control (scrambled shRNA). As previously noted, adiponectin 
is found circulating in what are often termed low, medium and high molecular 
weight oligomers corresponding to trimer, the first formed disulfide-linked 
oligomer (LMW), hexamer (MMW) and larger oligomers (HMW) (Tsao, 2014). As 
shown in Figure 2.2A in a non-denaturing, non-reducing gel for 4 hours of 
secretion, all Adpn multimers were affected to the same extent by alterations in 
Adrx expression. That is, secretion is inhibited in the knockdown cells and 
enhanced in the over expressing cells as compared to controls and this is shown 
quantitatively in Figure 2B. As noted in the Introduction, adiponectin and collagen 
have some similar features, disulfide bonds, a triple helical region and post-
translational modifications, and we also determined the effects of altered Adrx 
expression on collagen secretion. It is inhibited or enhanced, respectively, by 
Adrx knockdown and over expression (Figure 2.2 C). Moreover and like cultured 
fat murine cells (Figure 2.2B), siRNA mediated knockdown of Adrx in primary 
human adipocyte cultures inhibited the secretion of all adiponectin oligomers 
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(data not shown). Thus, these aspects of Adrx biochemistry in vitro appeared 
identical in mouse and human fat cells.  
If the overall effect of Adrx expression levels results in altered assembly of 
mature proteins, hence altered secretion, we would expect that cell-associated 
adiponectin would be enhanced by its knockdown and decreased by its over 
expression and this is exactly what we observe (Figure 2.2D). In addition, the 
insulin receptor which has numerous intra- and inter-molecular disulfide bonds 
(McKern et al., 2006) also shows altered expression due to Adrx manipulation, as 
expected, less receptor in the knockdown and more in the over expressers 
(Figure 2.2D and 2.2E). In this case, it was the steady state levels of an integral 
membrane protein that were being altered. 
Adiporedoxin is a redox-regulated protein, which catalyzes the oxidation of 
ER chaperones  
 To directly confirm that Adrx functioned as a redox-regulated protein, we 
used N-ethylmaleimide PEGylation (Sugiura et al., 2010) to assay for changes in 
the adipocyte ER oxidation state as reflected by mobility shifts in Adrx and 
PDIa1.  This reagent covalently reacts with reduced cysteines and retards protein 
mobility by 2K when run in non-reducing SDS-PAGE.  As shown in Figure 2.3A, 
control cells exhibited a mixture of oxidized and reduced PDI and Adrx, cells 
treated with the strong oxidizing reagent diamide (Hansen et al., 2009) showed 
fully oxidized proteins and cells treated with the reducing agent, dithiothreitol 
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(DTT), showed reduced mobility due to PEGylation. As a control, a mutant Adrx 
(Mut) lacking the two active site cysteines did not show this shift (Figure 2.3A, 
right hand panel). 
 To determine if Adrx could affect protein secretion through re-oxidation of 
chaperone proteins, we determined the redox state of PDIa1 in cells over and 
under expressing adiporedoxin (Figure 2.3B & 2.3C). Knocking down Adrx 
decreased the oxidized form of PDIa1 in the basal state and in response to all 
doses of hydrogen peroxide (Figure 2.3B). Overexpression of Adrx caused a 
slight but statistically insignificant increase in the oxidized forms of PDIa1 (Figure 
2.3C) consistent with the enhanced secretion under these conditions.  
Adrx expression levels affect the adipocyte proteome 
 We used Tandem Mass Tag technology (TMT) and quantitative mass 
spectrometry (Ting et al., 2011; Viner et al., 2009) to interrogate the proteome of 
control 3T3-L1 adipocytes (CON) and Adrx overexpressing (OE) and knockdown 
(KD) adipocytes. Overall, we were able to identify ca. 4500 proteins at a 1% 
protein false discovery rate (data not shown).  Principal component analysis 
(Figure 2.4A) of the proteomic data show good agreement between the biological 
replicates, and we observed that the majority of the proteome was unaffected by 
Adrx expression. Figure 2.4B shows a heat map of all proteins quantified and 
Gene ontology (GO) enrichment analysis for proteins in the overexpressing cells 
showed a significant increase in cell associated oxidoreductase and thioredoxin-
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related proteins and decreases in secreted adiponectin and collagen (Figure 
2.4C), the latter two as would be expected from the data of Figure 2.2. Thus the 
amount of cell-associated, disulfide-bonded adipokines, adiponectin (Adpn) and 
resistin (Rtn) (Banerjee and Lazar, 2001; Steppan et al., 2001) was less than in 
controls in the Adrx overexpressing cells and increased (cell retention) in the 
Adrx knockdown cells. On the other hand, serum amyloid A3 protein, which lacks 
S-S bonds (Meek et al., 1992), does not change as a result of altered Adrx 
expression (Figure 2.4C). The expression of the three specific collagen chains 
indicated in Figure 2.4C were affected by alterations in Adrx levels in a manner 
similar to adiponectin in confirmation of the biochemical analysis of Figure 2.2C. 
Adrx null mice show decreased adipokine secretion, have mild ER stress 
and are hyperinsulinemic. 
 In order to obtain data for the effects of Adrx levels in vivo, we introduced 
into mice, ES cells obtained from KOMP for a gene construct that deletes exons 
2-6, and we generated Adrx knockout mice. The mRNA expression for WT, 
heterozygous and Adrx null mice is shown in Figure 2.5A and protein expression 
data for the WT and knockouts are shown in Figure 2.5B and quantitatively 
analyzed in Figure 2.5C. The mice exhibited increased adiponectin retention and 
increases in components of the ER protein maturation machinery, BiP and 
ERo1a (Figure B, C) as well as in a number of mRNAs encoding ER stress 
proteins and inflammatory markers (data not shown). Mass spectrometric 
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analysis of intact epididymal fat tissue from WT and Adrx knockout mice 
confirmed that adiponectin and other adipokines show higher cellular levels 
(enhanced retention implying reduced secretion) in the knockout as compared to 
WT (data not shown), The WT and null mice are the same weight (Figure 2.5D) 
and body composition (data not shown), and the nulls have decreased levels of 
circulating HMW adiponectin (2.5E) as was expected from the in vitro data 
(Figure 2.2 and 2.3). The knockout mice have normal blood glucose (Figure 2.5F) 
are mildly hyperinsulinemic (Figure 2.5G), but have normal glucose tolerance 
(Figure 2.5H). 
Adrx null mice are protected from fibrosis due to decreased collagen 
deposition. 
Remarkably, while the epididymal adipose tissue from WT mice at age months 7 
shows fibrosis, the epididymal adipose tissue from Adrx null mice is essentially 
free from fibrosis (Figure 2.5I), and the null mice had lower levels of 14 collagen 
isoforms including collagen chains 6a1, a2, a3 & a5, the most abundant species 
found in adipose tissue as determined by mass spectrometry (Supplemental 
Table S2). Biochemical analysis of total collagen confirmed the mass 
spectrometry data (Figure 2.5J). Thus the in vivo collagen expression data are 
consistent with the adipose tissue staining (Figure 2.5I) and the results from the 
in vitro mass spectrometry analysis and quantification (Figure 2.2C and 2.4C). 
Interestingly, at age 6-7 months, the Adrx null mice are the same weight and 
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body composition as wild type mice, have identical glucose tolerance but have 
significantly higher fasting insulin (data not shown). 
Adrx is expressed in human adipocytes and down regulated in proportion 
to obesity and inflammation.  
Adrx mRNA and protein (Western blot analysis) levels in human adipose tissue 
were tightly correlated with adipose tissue adiponectin mRNA and protein levels, 
respectively, in both sexes (quantitative analysis, Figure 2.6A, males, 2.6B, 
females) after statistical adjustment for BMI, which had a negative effect on 
adiponectin mRNA and protein levels (Figure 2.6A & B, right panels).  Tissue 
Adrx protein levels were inversely related to the ratio of pJNK to total JNK protein 
for fat cells of both sexes (Figure 2.6C), pJNK being a marker of inflammation in 
human adipose tissue (Harte et al., 2013), and this association was independent 
of BMI in multiple regression models (data not shown). In addition, male mice fed 
a high fat diet showed reduced Adrx levels and reduced circulating adiponectin 
whereas females do not show any altered Adrx expression or adiponectin levels 
on this diet (data not shown). 
Discussion:  
 We describe herein the actions of adiporedoxin (Adrx), a novel protein 
highly enriched in adipocytes and localized to the endoplasmic reticulum, whose 
altered expression in vitro in mouse and human cells, and in vivo in mice, results 
in significant changes in adipocyte protein secretion. In particular, its knockdown 
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in mouse and human fat cells resulted in a significant attenuation of adiponectin 
secretion (Figure 2.2, 2.4), a protein whose expression has been linked with 
insulin sensitivity (Ye and Scherer, 2013) and the secretion of collagens (Figure 
2.2, 2.4, 2.5), proteins which can cause adipocyte fibrosis and insulin resistance 
(Sun et al., 2013). Both types of proteins require disulfide bonds for assembly 
and secretion. Moreover, we showed by proteomic analysis that Adrx over and 
under expression enhanced and attenuated, respectively, the secretion of several 
S-S bonded adipokines including resistin (Figure 2.4) and adipsin (Western blot 
not shown) as well as affected insulin receptor amounts (Figure 2.2), the latter 
presumably due to its large number of disulfide linkages (McKern et al., 2006). As 
most secreted proteins have disulfide bonds, appropriate controls are scarce for 
the measuring the effects of Adrx on secreted proteins lacking disulfides. 
However, serum amyloid A protein is such a protein (Meek et al., 1992), and its 
secretion is in fact unchanged in by manipulation of Adrx expression (Figure 2.4). 
Importantly, we confirmed much of the protein secretion data in studies of Adrx 
null mice (Figure 2.5), which circulate lower levels of HMW adiponectin and are 
remarkably free of fibrosis due to impaired collagen secretion. Lastly, Adrx mRNA 
and protein levels in human fat tissue correlate well with adiponectin mRNA and 
protein expression, and inversely to inflammatory markers, and thus the ability to 
maintain healthy adipose tissues despite obesity (Figure 2.6). 
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The data we obtained are consistent with Adrx acting at an early step in the 
secretory pathway of adipocytes.  Thus reduced Adrx expression in the context of 
ER oxidative stress (hydrogen peroxide, Figure 2.3) results in impaired redox 
regulation of PDIa1, the most abundant adipocyte chaperone found in our 
proteomic analysis of mouse adipose tissue, which is directly involved in disulfide 
bond formation (Appenzeller-Herzog and Ellgaard, 2008). Adrx appears to be in 
the peroxiredoxin (Prx) family of redox-regulated proteins (Xu et al., 2010) that 
have diverse biological functions in a variety of cell types, reduction of peroxides 
being their eponymous activity (Rhee et al., 2012). The only other endoplasmic 
reticulum localized peroxiredoxin, Prdx4, functions in the formation of disulfide 
bonds indirectly, probably by regulating the amount of reactive oxygen species, 
principally hydrogen peroxide (Zito, 2013; Zito et al., 2010b). As noted, disulfide 
bond formation is directly mediated by protein disulfide isomerases (PDIs) whose 
active sites have two or three -CGHC- sequences along with a chaperone fold 
consisting of about 130 amino acids with four beta sheets and 3 alpha helices 
(Appenzeller-Herzog and Ellgaard, 2008). The PDIs bind to substrates, form and 
if necessary, reform and correct their disulfide bonds, although many details of 
the process remain unclear (Sato et al., 2013). On the other hand adiporedoxin 
has a unique thioredoxin active site sequence, -CFLC-, not found in other PDI/Trx 
proteins, nor in the other peroxiredoxin family members, including Prdx4, as 
peroxiredoxins have cysteines widely separated in their primary protein 
46	
sequences and function as multimers (Rhee et al., 2012). Moreover, unlike most 
members of the PDI family and Prdx4, which are soluble in the lumen of the 
organelle, Adrx is a transmembrane protein (Figure 2.1) similar to the 
transmembrane thioredoxin-like protein 4 (TMX4) only with respect to its ER 
membrane location (Roth et al., 2010; Sugiura et al., 2010).  
Based on the data of Figure 2.3, we hypothesize that Adrx has a function unique 
to adipocytes that likely involves its ability to deal with metabolically related ER 
oxidative stress and to mediate protein secretion under these conditions. Recent 
related work on the role of various ER proteins involved in oxidative protein 
folding and disulfide bond formation has revealed redundancies and 
complementary roles for multiple PDI/Trx-related proteins (Sato et al., 2013; Zito 
et al., 2010b), fourteen of which are expressed in the adipocyte ER. The 
relatively modest metabolic phenotype of the Adrx null mice, like that of the 
ERo1a/ERo1b double knockout (Zito et al., 2010a), likely reflects this complexity 
and redundancy in ER oxidative function. On the other hand, the biochemical 
phenotype of the Adrx null mouse with regard to collagen secretion is particularly 
robust. In any case, considerable additional work will be required to define the 
biochemical role of Adrx more precisely and its hierarchical role in adipocyte ER 
redox regulation, and this is in progress. Adrx has previously been reported in 
one publication naming it peroxiredoxin 2-like protein expressed in bone marrow 
monocytes (PAMM, also known as Fam213a) (Xu et al., 2010) that affects 
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cellular redox status, a result consistent with the present data. Its expression in 
fat tissue was not examined in the cited study, but the authors showed protein to 
be expressed in human liver, brain and other tissues, at what appears to be one 
or more orders of magnitude lower than in adipocytes, as compared to our data 
on Adrx levels in these tissues (Figure 2.1). Hence a biochemical role for Adrx in 
other cells is likely, but to a significantly lesser magnitude than that in adipocytes. 
A second aspect of Adrx function in adipocytes concerns the biochemical nature 
of the most abundant secreted molecules of these cells, adiponectin and 
collagen. These proteins are particularly interesting, not only for reasons of their 
abundance and important physiological role(s), but also for the fundamental 
biochemistry and cell biology of their complicated quaternary structures, post 
translational modifications including intermolecular disulfide bond formation 
(Bourhis et al., 2012; Liu and Liu, 2010). The adiponectin trimer consists of an 
intermolecular disulfide link between 2 monomers and a free SH group on the 3rd 
subunit, which is then disulfide bonded to another trimer to form the hexamer 
(Pajvani et al., 2003; Tsao et al., 2003; Waki et al., 2003). Likewise, intrachain 
disulfide bonds between the N- and C-terminal propeptide sequences are 
necessary to form the signature triple helix structure of collagens (Bourhis et al., 
2012) before their movement out of the ER. The striking biochemical phenotype 
of the Adrx knockout mouse emphasizes Adrx’s roles as a particular modulator of 
collagen secretion and that of related proteins. Regarding adiponectin, previous 
48	
studies have documented a direct interaction of an adiponectin cysteine residue 
with one in ERp44, which bond can be released by reducing agents or by 
increasing ERo1a levels (Wang et al., 2007). This mechanism, enhanced 
retention, is analogous to the assembly of IgK (Anelli et al., 2003; Anelli et al., 
2002). However, adipsin has only intermolecular disulfides (Perkins and Smith, 
1993) and the insulin receptor has both types of bonds (McKern et al., 2006). 
This would support the above stated notion that Adrx plays a broad role early in 
disulfide bond formation, e.g. ER redox status, such that a compromise in its 
activity reduces the overall levels of most or all disulfide bonded integral 
membrane and secreted proteins. DsbA-L was shown to directly interact with 
adiponectin in yeast-2 hybrid studies and to promote its multimerization (Liu et 
al., 2008). DsbA-L was also shown to alleviate the effects of adipocyte ER stress 
on adiponectin levels (Zhou et al., 2010). However, it does not appear to be a 
luminal ER resident (Figure 2.2), presumably a requisite for a direct role in 
oligomer assembly, and its knockout in mice is without effect on adiponectin 
multimerization (Theodoratos et al., 2012). Thus a further examination, in vitro 
and in vivo, of the possible players in adipocyte protein secretion is needed to 
resolve the specific roles of these proteins in the formation of adipokines and 
integral membrane proteins and to further elucidate the mechanism(s). 
 Given its pleiotropic action on adipokines and other secreted proteins 
related to insulin sensitivity, the relationship of Adrx levels to pathophysiological 
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states in mice and humans is likely to be complex. Indeed we see no dramatic 
effects of Adrx deficiency on systemic glucose metabolism in mice on a chow diet 
despite lower adiponectin levels and hyperinsulinemia, factors that can 
contributor to insulin resistance. However, fibrosis, while present in WT animals, 
is virtually absent in the epididymal fat pad of older Adrx deficient mice, and this 
should enhance the metabolic flexibility and the insulin sensitivity of adipose 
tissue and the entire mouse and would therefore compensate for the effects of 
hypoadiponectinemia and hyperinsulinemia. In human adipose tissue we also 
found a close correlation between Adrx and adiponectin mRNA levels and in their 
protein expression in both men and women, independent of BMI, which exerted 
an independent negative influence on adiponectin protein expression as might be 
expected.  Furthermore, higher expression of activated (phosphorylated) JNK, a 
marker of ER stress, inflammation and insulin resistance(Harte et al., 2013) was 
inversely correlated with Adrx protein (Figure 2.6). In WT male mice following 12 
weeks of a high fat diet, which results in insulin resistance, reduced adipocyte 
Adrx protein correlates with lower circulating adiponectin. However in comparing 
data for the 2 species, it is necessary to note we used clonal mouse strains 
(Figure 2.5), whereas there are inherently more individual variations in human in 
gene expression, adipose tissue inflammation and insulin resistance. We 
postulate that Adrx may be down regulated in response to the metabolic and 
inflammatory status of the adipose tissue and this mechanism contributes to 
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lower adiponectin levels in obese humans, which is likely to be one of several 
factors influencing the metabolic status of the individual. Thus, adiporedoxin is 
clearly an important contributor to fat cell biology in mice and humans and one 
that participates in and regulates novel aspects of the secretory pathway in these 
cells of relevance to basic cellular functions, organismal metabolism and 
pathology. 
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Experimental Procedures  
 
Animals. Male Sprague-Dawley rats (175-200 g, Harlan Laboratories) were 
decapitated following CO2 anesthesia, epididymal fat pads were removed by 
dissection, subjected to collagenase digestion and isolated by flotation as 
described(Jedrychowski et al., 2010). Age matched, 8 week old C7BL/6 male and 
female mice were purchased from Jackson Laboratory and maintained at 22°C 
with a light-dark cycle (light from 0700 to 1900h), and allowed free access to food 
and water.  At 10 weeks of age, mice were body weight matched into groups fed 
under either HF (45% of calories, mainly as lard) or LF diets (10% of calories 
from fat) (Research Diets, Inc., New Brunswick, NJ, USA) for 14 weeks.  At the 
end of the LF/HF feeding and after 4 hr. fast, mice were decapitated after CO2 
anesthesia. All females were euthanized at pro-estrus phase. For Adrx tissue 
distribution, mice were perfused with PBS, tissues were carefully dissected with 
particular attention to removing any fat, immediately mechanically homogenized 
in a tissue grinder with RIPA buffer containing a protease inhibitor cocktail and 
subjected to a 1000 x g spin to remove debris. The supernatant was collected for 
SDS-PAGE and Western blot analysis. For fat tissue the infranatant below the fat 
cake was collected for analysis.  
The Adrx knockout mice were generated by microinjecting targeted ES cells 
(KOMP, derived from C57BL/6N, VG15730, clone 15730A-H5) into C57BL/6N 
blastocysts, and these gave rise to male chimeras with significant ES cell 
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contribution (as determined by coat color). By mating with C57BL/6N females 
and genotyping the offspring by PCR analysis, germ line transmission was 
confirmed. Male and female heterozygous F1 animals were interbred to obtain 
Adrx knockout (Adrx KO) animals. Male animals only were analyzed at >8 weeks 
of age. The animals were maintained in a pathogen-free animal facility at 21°C 
under a 12-h light/12-h dark cycle with access to a standard rodent chow.  Except 
when specifically noted, all mice used for in vivo or in vitro studies were fasted for 
4-6 hours starting from early morning prior to use. For tissue harvesting, mice 
were sacrificed under CO2 anesthesia, and tissues were rapidly taken and 
immediately frozen in liquid nitrogen and stored at -80°C until biochemical 
analyzed. Tissue and cell secreted collagen content was measured using Sirius 
Red Total Collagen Detection Kit (Chondrex, 9062).  Mouse serum total and 
HMW adiponectins were measured by using ELISA kit from ALPCO (47-ADPMS-
E01). 
Cell Culture.  Murine 3T3-L1 cells were cultured, differentiated, and maintained 
as described previously (Stephens et al., 1997).  Human embryonic kidney 
(HEK)-293T cells were cultured in DMEM with 10% FBS. For Adrx 
overexpression, confluent 3T3-L1 fibroblasts were infected with a pBABE 
retrovirus construct driving Adrx cDNA using the following oligo primers: sense 
sequence containing BamH1 restriction site, 5’-ttttggatccatgtcttttctccaggac-3’ and 
an antisense sequence containing an EcoR1 restriction site, 
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5’ttttgaattctcagcttctcccggacgctggagt-3’, then differentiated for subsequent 
analysis as fat cells. Site directed mutagenesis of Adrx was performed using a 
Quickchange Mutagenesis Kit (Aligent, Santa Clara, California) following the 
manufacturer's instructions (see Supplemental Experimental Procedures  for 
primer sequences).  
For Adrx silencing, mouse lentiviral vectors driving several shRNA sequences 
were purchased from Open Biosystems (Huntsville, AL) and transfected into 
HEK-293T cell with trans-IT 293 (Mirus, Madison, WI) according to the 
manufacturer’s instructions. Supernatant containing retrovirus was harvested 48 
hrs later and used to infect confluent 3T3-L1 fibroblasts prior to their 
differentiation. Four pLKO.1 c10orf58 mouse lentiviral vectors (sense loop 
antisense, see Supplemental Experimental Procedures) were tested. All 
sequences were effective with target # 3 showing the best knockdown efficiency 
(>90%), and it was used for all of the adiporedoxin studies. 
Pegylation Assay. 3T3-L1 cultured adipocytes at day 8 of differentiation were 
treated with 5 mM dithiothreitol (DTT) for 5 min, 3 mM diamide for 5 min, or 
various concentrations of H2O2 for 10 min. Cells were denatured and precipitated 
in ice-cold PBS containing 20% trichloroacetic acid (TCA), incubated on ice for 1 
h, and centrifuged at 10,000 rpm for 15 min at 4°C. The supernatant was 
discarded and the pellet was washed 3 times with ice-cold acetone, dried, and 
resuspended in reaction buffer (80 mM Tris-HCl, pH 6.8, and 2% SDS) containing 
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5 mM methoxypolyethylene glycol (average molecular weight, 2000)-maleimide 
(MalPEG-2K) (NOF Corporation) (Sato et al., 2013). Samples were left in the 
dark for 60 min at room temperature. The alkylation reaction was stopped by 
boiling for 5 min after the addition of an equal volume of 4× Laemmli loading 
buffer.  
 
Primary human adipose cells. Human adipose stromal vascular cells (SVC) 
were isolated from adipose tissue by collagenase digestion, grown and 
differentiated as previously described (Lee et al., 2012a). Adipocytes (day 10 
post differentiation) were transfected with control or a combination of two Adrx-
directed siRNA (SI04213587 and SI04959066, Qiagen) using Lipofectamine and 
PLUS reagents (Life Technologies).  
Fractionation of Adipocytes. Primary rat fat cells were fractionated as 
described by Jedrychowski et al {Jedrychowski, 2010 #115}. Cultured 3T3-L1 fat 
cells were fractionated and subjected to sucrose gradient centrifugation in an 
identical protocol. 
Primers The following primers were used to generate the 85CFL88C to 85SFL88S 
mutants: 5’-caggcccaggcagctttctcagccgagcg-3’, 3’-
tccgctcggctgagaaagctgcctggcc-5’. 
For Adrx knockdown: 
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Target #1 Open Biosystems catalog # TRCN0000176473 
ccggcggtatttgaagtgaagtttactcgagtaaacttcacttcaaataccgttttttg;  
Target #2 Open Biosystems catalog # TRCN0000177317 
ccgggatttccaaccttacttcaaactcgagtttgaagtaaggttggaaatcttttttg;  
Target #3 Open Biosystems catalog # TRCN0000182236 
ccggcccagacagaacagagttcaactcgagttgaactctgttctgtctgggttttttg;  
Target #4 Open Biosystems catalog # TRCN0000182272 
ccgggaggcggaagatgatgttcatctcgagatgaacatcatcttccgcctcttttttg 
Gel Electrophoresis and Immunoblotting. Proteins were resolved by SDS-
PAGE as described  59. Non-denaturing PAGE separation of adiponectin 
oligomers was performed as described 12. Gels were transferred to polyvinylidene 
difluoride (Biorad, Hercules, CA) membranes pretreated with methanol in 25 mM 
Tris, 192 mM glycine.  Membranes were blocked with 10% nonfat dry milk in PBS 
containing 0.1% Tween 20 for 1 hour at room temperature.  Membranes were 
then probed with the primary antibodies for either overnight at 4 °C or 2 hrs at 
room temperature and incubated with Horseradish peroxidase-conjugated 
secondary antibodies (Sigma).  Signals were enhanced with chemiluminescence 
reagents (Perkin Elmer Life Sciences, Boston, MA) for detection of Western 
signals using a Fujifilm LAS-4000 scanner or Autoradiography Film (Molecular 
Technologies, St. Louis MS). Antibodies to the indicated proteins were from the 
following sources: GLUT4 60; cellugyrin; IRAP and Adrx (21st Century 
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Biochemical, Hopkinton, MA); adipsin (Santa Cruz Biotechnology, Inc., Santa 
Cruz, CA); ERo1-α (Abnova, Taiwan, China); adiponectin (Affinity Bioreagents, 
Golden, CO); β-actin, tubulin (Sigma, St. Louis, Mo); DsbA-L and calnexin 
(Abcam, Cambridge, MA). Antibodies to the following were generous gifts: aP2 
(Dr. David Bernlohr, University of Minnesota), insulin receptor (Dr. Jongsoon Lee, 
Joslin Diabetes Center. 
Immunofluorescence. On Day 6 of differentiated as described, cells were 
trypsinized and plated onto coverslips in 6 well plates. On day 8 of differentiation 
cells were fixed with 4% paraformaldehyde in PBS for 15 minutes at room 
temperature and permeabilized with 0.1% saponin (Sigma), 0.4% BSA in PBS 
(solution A) for 10 minutes and then blocked for 1 hour at room temperature in 
5% normal goat serum (Sigma) in PBS. Primary antibodies were incubated with 
fixed cells overnight at 4°C at a dilution of 1/100 in 1% normal goat serum in 
PBS. After staining cells were washed four times with solution A and incubated 
with Alexa-Fluor 488 anti-mouse or Alexa-Fluor 555 anti-rabbit (Invitrogen) at a 
dilution of 1/1000 in 1% normal goat serum in PBS for 1 hour at room 
temperature.  The cells were washed again for 3 times with solution A and then 
mounted with Vectashield mounting medium with DAPI (Vector Laboratories, Inc. 
Burlingame, CA, USA). The stained cells were observed using a Nikon de-
convolution wide-field Epifluorescence system and images were processed using 
ImageJ software. 
57	
Mass Spectrometry. 
Sample preparation, protein digest, and peptide TMT-labeling. Cultured 
adipocytes were lysed with a mechanical homogenizer, disulfide bonds were 
reduced with DTT and cysteine residues alkylated with iodoacetamide essentially 
as previously described 61.  Protein content was measured using a BCA assay 
(Thermo Scientific, Rockford, IL.  Protein lysates were cleaned up by methanol-
chloroform precipitation and digested overnight with LysC (Wako, Japan) in a 
1/100 enzyme/protein ratio in 4 M urea and 50 mM Tris-HCl, pH 8.8. The digest 
was acidified with formic acid (FA) to a pH of ~ 2-3 and subjected to C18 solid-
phase extraction (SPE) (Sep-Pak, Waters, Milford, MA). Isobaric labeling of the 
peptides was accomplished with six-plex tandem mass tag (TMT) reagents 
(Thermo Scientific, Rockford, IL).  Reagents, 0.8 mg, were dissolved in 40 µl 
acetonitrile (ACN) and 15 µl of the solution were added to 100 µg of peptides 
dissolved in 100 µl of 50 mM HEPES, pH 8.5 After 1 hour at room temperature, 
the reaction was quenched by adding 8 µl of 5% hydroxylamine.  Peptides were 
labeled with all six reagents (126-131), combined and subjected to C18 SPE.   
Strong cation exchange (SCX) chromatography sample fractionation. 
Sample fractionation was performed by strong cation exchange (SCX) 
chromatography as previously described2. Briefly, the sample was resuspended 
in SCX buffer A (7 mM KH2PO4, pH 2.6, 30% ACN) and separated over a 4.6 x 
200 mm polySULFOETHYL A HPLC column (particle size, 5 µm; pore size, 200 
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Å; PolyLC, Columbia, MD).  The separation was done using applying a two-buffer 
(SCX A and B) gradient from 0 to 50% SCX buffer B (7 mM KH2PO4, 350 mM 
KCl, pH 2.6, 30% ACN) in 47 min at a flow rate of 0.9 ml/min, followed by 50 to 
100% SCX buffer A to buffer B in 4.5 min using an Agilent 1100 quaternary pump 
outfitted with a degasser and a photodiode array detector (PDA) (Thermo 
Scientific, San Jose, CA).  Samples were collected in 30 s increments into a 96-
well plate, and dried under vacuum. Fractions were then redissolved with 1% FA 
and – based on the intensity from the SCX chromatographic UV trace –combined 
into a total of 20 samples, which were desalted by C18 SPE, and dried under 
vacuum.  
Liquid chromatography electrospray ionization tandem mass spectrometry 
(LC-MS/MS). All LC-MS/MS experiments were performed on an LTQ Orbitrap 
Velos (Thermo Fischer Scientific) equipped with a Famos autosampler (LC 
Packings, Sunnyvale, CA) and an Agilent 1100 binary HPLC pump (Agilent 
Technologies, Santa Clara, CA). Peptides were separated on a 100 µm I.D. 
microcapillary column packed first with approximately 0.5 cm of Magic C4 resin 
(5 μm, 100 Å, Michrom Bioresources, Auburn, CA) followed by 20 cm of Maccel 
C18AQ resin (3 μm , 200 Å, Nest Group, Southborough, MA). Separation was 
achieved through applying a gradient from 9 to 32% ACN in 0.125% FA over 150 
min at approximately 300 nl/min. Electrospray ionization was enabled through 
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applying a voltage of 1.8 kV through a PEEK junction at the inlet of the 
microcapillary column.  
The LTQ Orbitrap Velos was operated in data-dependent mode for both MS2 and 
MS3 methods. For the MS2 method, the survey scan was performed in the 
Orbitrap in the range of 300-1500 m/z at a resolution of 3x104, followed by the 
selection of the ten most intense ions (TOP10) for HCD-MS2 fragmentation using 
a precursor isolation width window of 2 m/z. The AGC settings were 3 x 106 and 
2.5 x 105 ions for survey and MS2 scans, respectively. Ions were selected for 
MS2 when their intensity reached a threshold of 500 counts and an isotopic 
envelope was assigned. Maximum ion accumulation times were set to 1000 ms 
for survey MS scans and to 250 ms for MS2 scans. The normalized collision 
energy for HCD-MS2 experiments was set to 45% at a 30 ms activation time. 
Singly charged ion species and ions for which a charge state could not be 
determined were not subjected to MS2. Ions within a 10 ppm m/z window around 
ions selected for MS2 were excluded from further selection for fragmentation for 
120 s.  
The survey MS scan settings were identical for the MS3 method, where the ten 
most intense ions were first isolated for ion trap CID-MS2 at a precursor ion 
isolation width of 2 m/z, using an AGC setting of 2 x 103, a maximum ion 
accumulation time of 150 ms, and wide band activation. Directly following each 
MS2 experiment, the most intense fragment ion in an m/z range between 110-
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160% of the precursor m/z was selected for HCD-MS3. The fragment ion 
isolation width was set to 4 m/z, the MS3 AGC was 20 x 104 and the maximum 
ion time 250 ms. Normalized collision energy was set to 35% and 60% at an 
activation time of 20 ms and 50 ms for MS/MS and MS3 scans, respectively. 
Precursor ion selection settings were as in the MS2 method 35.  
Data processing: MS2 spectra assignment, data filtering and quantitative data 
analysis 
A suite of in-house developed software tools was used to convert mass 
spectrometric data from the RAW file to the mzXML format, as well as to correct 
erroneous assignments of peptide ion charge state and monoisotopic m/z. We 
modified the ReAdW.exe to include ion accumulation time in the output during 
conversion to the mzXML file format 
(http://sashimi.svn.sourceforge.net/viewvc/sashimi/). Assignment of MS2 spectra 
was performed using the Sequest algorithm by searching the data against a 
protein sequence database containing all known translated proteins from the 
mouse IPI database (version 3.60), and known contaminants such as porcine 
trypsin, and human keratin. This forward (target) database component was 
followed by a decoy component including all listed protein sequences in reversed 
order. Searches were performed using a 20 ppm precursor ion tolerance, where 
both peptide termini were required to be consistent with Lys-C specificity, while 
allowing up to two missed cleavages. Sixplex TMT tags on lysine residues and 
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peptide N termini (+ 229.162932 Da) and carbamido- methylation of cysteine 
residues (+57.02146 Da) were set as static modifications, oxidation of methionine 
residues (+ 15.99492 Da) as a variable modification. A MS2 spectral assignment 
false discovery rate of less than 1% was achieved by applying the target- decoy 
database search strategy. Filtering was performed using a linear discrimination 
analysis method to create one combined filter parameter from the following 
peptide ion and MS2 spectra properties: Sequest parameters XCorr and ∆Cn, 
peptide ion mass accuracy and charge state, predicted low pH (2.7) in-solution 
charge of peptide and peptide length. Linear discrimination scores were used to 
assign probabilities to each MS2 spectrum for being assigned correctly and these 
probabilities were used to filter the dataset with an MS2 spectra assignment false 
discovery rate of less than 1% to obtain a protein identification false discovery 
rate of less than 1.5% . 
For quantification, a 0.03 m/z window centered on the theoretical m/z value of 
each reporter ion was monitored for ions, and the intensity of the signal closest to 
the theoretical m/z value was recorded. Reporter ion intensities were 
denormalized by multiplication with the ion accumulation time for each MS3 
spectrum and adjusted based on the overlap of isotopic envelopes of all reporter 
ions. Intensity distributions of isotopic envelopes were as provided by the 
manufacturer. The total signal intensity across all peptides quantified were 
summed for each TMT channel, and all intensity values were normalized to 
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account for potentially uneven TMT labeling. The intensities for all peptides of a 
given protein were summed to derive an overall protein abundance value for 
each TMT signal. Hierarchical clustering using Pearsons correlational analysis 
was conducting using MultiExperiment Viewer (TM4 Microarray Software Suite) 
62 and Principle component analysis based on correlations was performed using 
JMP statistical software(version 10 Pro).  
Protein ratios across Adrx cell lines between KD to control and OE to control 
were calculated based on their normalized TMT ratios. Principle component 
(PCA) analysis, GO classifications and enrichment calculations were performed 
using DAVID online bioinformatics tools. The resulting clusters are plotted for GO 
Cellular Components, GO Biological Processes and GO Molecular Function 
annotations.  Representative proteins are highlighted with their corresponding 
ratios. 
Study approval. The animal studies were approved by the Institutional Animal 
Care and Use Committee and the human fat cells (next section) were obtained 
from subjects who gave informed consent as approved by Institutional Review 
Boards of Boston University School of Medicine. 
Others see details in Supplemental Experimental Procedures 
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Figure 2.1 Adiporedoxin (Adrx) is an endoplasmic reticulum targeted 
peroxiredoxin-related protein enriched in adipocytes. 
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A. The sequences and domains B. of mouse and human adiporedoxin are 
shown, highlighting the transmembrane region and the active site cysteines C. 
The tissue distribution of adiporedoxin and adiponectin (Adpn) is shown for equal 
protein amounts of cell lysates subjected to SDS-PAGE and Western blotting 
detection. D. Adrx protein expression is induced during 3T3-L1 cell differentiation 
from fibroblasts (day 0) to mature fat cells (day 8). An equal protein amount of 
cell lysates from the days indicated was subjected to SDS-PAGE and 
immunoblotted for the selected proteins. E. The internal membrane fraction (0.5 
mg protein) from isolated primary adipocytes was subjected to sucrose gradient 
centrifugation, odd-numbered fractions were collected and blotted for the proteins 
indicated, adiporedoxin (Adrx), calnexin (Cnx), cellugyrin (CG) and GLUT4. F. 
3T3-L1 cells were lysed, processed and subjected to sucrose gradient analysis 
as for the primary adipocytes of 1e. Additional proteins analyzed are adiponectin 
(Adpn), disulfide bond A oxidoreductase-like (DsbA-L), endoplasmic reticulum 
oxidoreductase 1-alpha (ERo1a). G. Immunofluorescence of differentiated 3T3-
L1 cells shows the co-localization of Adrx with calnexin and no mitochondrial 
(porin) association. The data for each part of this figure are representative of 
three or more independent experiments. 
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Figure 2.2 Adiporedoxin levels affect the secretion of adiponectin (Adpn) 
and collagen, and the insulin receptor (IR) levels. 
Day 8 differentiated murine adipocytes (3T3-L1) infected with Adrx shRNA, WT 
Adrx cDNA (OE) or a scrambled sequence (-) were washed 3X with serum free 
medium, and then incubated for 4 hours (A-C). Cell lysates and supernatants 
were harvested, subjected to SDS-PAGE and Western blotted for the indicated 
proteins. A. Cell supernatants from a representative experiment were collected 
from control (-), knockdown (shRNA, +) and Adrx overexpressing cells (OE, +) 
after 4 hours and subjected to non-denaturing, non-reducing gel electrophoresis 
B. The results of scanned gels for the 3 forms shown in A, HMW, MMW and 
LMW, are given as the S.E.M., n=3, P< 0.001 for the over expressers and n=9, 
P< 0.002 for the shRNA cells, control value set to %100. C. Collagen secretion 
was measured in a separate series of experiments as in A and the results are 
from n experiments, P<??? D. Shown is a representative experiment for Adrx 
knockdown and over expressing cells where lysates were prepared and 
subjected to SDS-PAGE under reducing conditions showing the total cellular 
levels of Adrx, Adpn and the insulin receptor (IR). E. Western blotting data for the 
insulin receptor beta subunit following SDS-PAGE were scanned and statistically 
analyzed (n=4, *p <0.02, **p <0.002).  
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Figure 2.3 Adiporedoxin is upstream of PDI in the adipocyte ER redox 
cascade. 
A. 3T3-L1 cells over-expressing WT Adrx or with active site cysteines mutated to 
serines (85SFLS88) were treated or not with Diamide (Dia.) or dithiothreitol (DTT) 
for 5 minutes, lysed with 20% TCA, and TCA precipitates were reacted with 
MalPEG-2K to modify free cysteines. Adrx and protein disulfide isomerase a1 
(PDIa1) were visualized by immunoblotting following gel electrophoresis of the 
TCA precipitates B. 3T3-L1 cells expressing scrambled or Adrx-targeting shRNA 
were treated with various concentrations of H2O2 for 5 min., lysed and treated as 
in Figure 3A. Cnx is calnexin, the loading control. The bar graph on the right 
shows the mean ± S.D. for scans of 4 independent experiments (*p< 0.05). C. 
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Same as Figure 3B for Adrx over expressing cells and controls (scrambled 
shRNA). 
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Figure 2. 4 Proteomic analysis of tandem mass tagged (TMT)-labeled whole 
cell (3T3-L1) lysates confirms Western blot data and reveals pleiotropic 
cellular changes as result of altered Adrx levels 
A. Principle component analysis (PCA) analyses of the TMT labeling (Table 1, 
Supplemental) showed good correlation between biological replicates. 
Eigenvalues and percentages were calculated for each PCA.  Graphical 
representation for each protein by PCA 1 and PCA 2 show the majority of the 
70	
proteins did not change as a result of altered Adrx levels.   Biplots of PCA 1 and 
2 show a vector location of each biological sample where the biological 
duplicates were found to be most similar to each other. B. Heat map showing 
enrichment of Gene Ontology (GO) categories across Adrx cell lines. Indicated to 
the right of the heat map are those categories that were significantly enriched 
with Benjamin-Hochberg corrected p < 0.05. C. Relative amounts of cell 
associated adipokines (adiponectin, Adpn; resistin, Rtn; serum amyloid a, SAA) 
and selected collagens (Col1a, 3a, 6a) from Adrx knockdown (KD) and 
overexpressing (OE) as compared to control (Cont-set to 1.0). The results shown 
for the TMT experiment compare 2 dishes of each cell line (OE, KD, Cont, see 
Supplemental Table 1) and the entire experiment was repeated twice with similar 
results. 
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Figure 2.5 Adrx null mice show ER stress, hyperinsulinemia and their 
adipose tissue is free of fibrosis.   
A. Adrx mRNA levels from adipose tissue were examined by RT-qPCR from wild 
type (WT), heterozygote (Het) and Adrx knockout (KO) mice. B. Whole adipose 
tissue lysates from WT and KO mice were prepared in RIPA buffer. Protein (10–
50 mg, equal amounts, WT & KO) was subjected to SDS-PAGE and 
immunoblotted with the indicated antibodies. C. Quantification of Adrx, Adpn, Bip 
and Ero1a from 6B, body weight (D), fasting serum insulin (E) and glucose (F), 
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HMW adpn (G), and glucose tolerance test (H) were assessed in WT and Adrx 
KO mice. I. Collagen Masson's Trichrome Stain and J. collagen quantification by 
using Sirius Red Total Collagen Detection Kit of adipose tissue from WT and 
Adrx KO mice. 8-week-old strain-matched males were used in (a-h), n=3, and 7 
months old mice were used in (I-J), n = 6. The statistical values are displayed as 
means and S.E. (*p < 0.05, **p < 0.01, ***p < 0.001). 
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Figure 2.6 Tissue levels of adiponectin and adiporedoxin protein positively 
and strongly correlate independent of BMI and negatively with phospho-
jun kinase (pJNK). 
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Values were determined by densitometric analysis of Western blots for Adrx and 
adiponectin from whole cell lysates in men A. and women B. (each sex run on 
different blots so values not directly comparable).   Associations were analyzed in 
a least squares model that including the interaction term Adrx*BMI which was 
significant in the females (p=0.01) but not in the males (p=0.12).  The model 
predicted 60% of the adiponectin variance in the females (R2 = 0.60, n = 30, 
p<0.001), and 62% in males (R2 = 0.62, n = 16, p< 0.01). C. Quantitative analysis 
of Western blots of adipocyte lysates for the ratio of p-JNK to total JNK plotted 
versus Adrx for both sexes shows a negative correlation in both males (r = -0.68, 
n = 16) and female subjects (r = -0.49, n = 29, one outlier excluded). 
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Abstract: 
 
 While greater adiposity is associated with the metabolic syndrome, a 
mechanistic link to increased fat mass and metabolic dysfunction remains 
elusive. One possible candidate is hypoxia and subsequent oxidative stress, 
which occurs as a direct result of adipose tissue growth. Oxidative stress in the 
form of excess reactive oxygen species (ROS) inhibits endoplasmic reticulum 
(ER) function and importantly, adipokine secretion. Recently, we discovered an 
adipocyte enriched redox protein, localized to the ER, which mediates oxidative 
protein folding and global protein secretion in fat. Here we show that during 
oxidative stress adiporedoxin (Adrx) is upregulated by HIF1a in response to an 
increase in ROS during both hypoxia and menadione treatment. Adrx acts as an 
antioxidant, reducing ROS during basal and oxidative stress conditions. 
Overexpressing Adrx in adipocytes, protected the ER from both sources of 
oxidative stress and rescue adipokine secretion. In mice, Adrx is increased in 
adipose tissue, along with HIF1, after 3 days of HF feeding, conditions known to 
increase acute oxidative stress. Adrx knock out animals showed higher oxidative 
stress in adipose tissue under the same conditions. Our results support the 
hypothesis that Adrx is an important mediator of adipose tissue oxidative stress. 
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Introduction: 
 
Increased adiposity often corresponds with adipocyte dysfunction and the 
metabolic syndrome but the mechanistic connection between these events is not 
fully understood.  Adipocyte hypoxia and oxidative stress occur early in the 
metabolic syndrome and could be a direct link between adipose tissue expansion 
and adipocyte dysfunction. As fat mass expands during obesity, changes to the 
vasculature restrict blood flow and oxygen to adipose tissue (Sun et al., 2011a; 
West et al., 1987).  This leads to chronic hypoxia in the adipocytes when oxygen 
supply cannot satisfy demand (Hosogai et al., 2007; Kabon et al., 2004). While 
hypoxia plays an important role in normal physiology, it also induces oxidative 
stress, defined as an imbalance between cellular ROS and antioxidant defenses, 
through NADPH and mitochondrial deregulation (Poyton et al., 2009).  On a 
cellular level, excess ROS causes protein, lipid, and DNA damage, leading to 
cellular dysfunction and death, and is an underlying cause of many metabolic 
diseases, including diabetes, hypertension, and atherosclerosis (Furukawa et al., 
2004).  
Adipocytes are particularly sensitive to oxidative stress and hypoxia.  The 
magnitude of an adipocyte’s influence systemically is due, in part, to the cell’s 
high secretory function, which is disrupted during oxidative stress (Hosogai et al., 
2007). These secreted proteins, including extracellular matrix proteins and 
signaling adipokines, are far reaching regulators of important metabolic 
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processes including: inflammation and immune response (e.g. adipsin, 
interleukins). Glucose metabolism and insulin sensitivity (e.g. adiponectin, 
resistin), appetite regulation and energy expenditure (e.g. leptin), cell adhesion 
(e.g. plasminogen activating factor 1), and hypertension (e.g. angiotensin) 
(Bluher and Mantzoros, 2015; Cusin et al., 1996; Engeli et al., 2003; Rock et al., 
1996; Tsao et al., 2003; Yamauchi et al., 2001).  A change in adipokine levels 
has profound affects on overall metabolism, clearly demonstrated by the robust 
metabolic health of the adiponectin over expressing transgenic mouse, even 
though it is fattest mouse ever generated (Kim et al., 2007a).  
Hypoxia and oxidative stress severely impair adipocyte protein secretion 
through multiple mechanisms. Individually, many influential secreted proteins are 
now known to be hypoxia sensitive genes including leptin and interleukin-6 (IL-6), 
which are upregulated during hypoxia and adiponectin (Adpn), which is 
downregulated (Hosogai et al., 2007). A more general consequence is the 
disruption of oxidative folding and ER stress. The great majority adipocyte 
secreted proteins require at least one disulfide bond for proper secretion and 
function, formed through a redox transfer cascade involving many thioredoxins, 
peroxiredoxins, and oxidoreductases (Braakman and Bulleid, 2011; Galic et al., 
2010). An increase in ROS and hyperoxidation of the ER causes nonspecific 
disulfide bonds and misfolded proteins, triggering the unfolded protein response 
and protein degradation.   
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A second function of adipocytes, insulin mediated glucose uptake, is also 
inhibited by oxidative stress and hypoxia.  Markers of oxidative stress are 
strongly correlated with obesity and insulin resistance in vivo, even preceding 
diabetes and the metabolic syndrome (Lee, 2001; Smith et al., 2003; Urakawa et 
al., 2003). This identifies oxidative stress as a cause of insulin resistance and not 
a byproduct of hyperglycemia or other disease pathologies.  While the exact 
mechanism by which oxidative stress inhibits insulin signaling is not yet known, 
elevated cellular ROS naturally occurs in adipocyte models of diabetes, and 
insulin resistance is easily induced in healthy adipocytes after the accumulation 
of ROS (Houstis et al., 2006; Rudich et al., 1998).   
Antioxidant therapy has been explored for the treatment of the metabolic 
syndrome with poor results, possibly due to indirect targeting or weak antioxidant 
properties (Golbidi et al., 2011). Recently, we discovered a fat specific 
thioredoxin fold protein with the ability to participate in redox reactions and 
required for proper endocrine function in adipocytes (Chapter 2) (Jedrychowski et 
al., 2010). Despite its lack of active site homology with the peroxiredoxin family, 
Adrx shares structural similarities with peroxiredoxins and glutathione 
peroxidases, both potent antioxidants. Here we show that Adrx is oxidized in the 
presence of exogenous hydrogen peroxide and acts as an antioxidant to mediate 
oxidative stress and preserve protein secretion in adipocytes. 
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Results: 
 
Adiporedoxin is upregulated during oxidative stress 
To further understand the role of Adrx in adipocyte redox homeostasis we 
exposed 3T3-L1 adipocytes to several compounds known to affect the dynamics 
of the ER (Figure 3.1 A). Adrx expression appears to be stable in the presence of 
classical ER stressors thapsigargin, tunicamycin, and hypoxia, with no change in 
protein levels after 24 hours. However, we did notice a disruption in Adpn, a 
secreted protein which correlates with Adrx function, during hypoxia (Figure 3.1 
A). Exploring the effect of hypoxia over shorter time points revealed Adrx protein 
expression increases 50% during acute hypoxic conditions and decreases with 
long-term exposure, possibly due to cell toxicity (Figure 3.1 B-D).  While Adpn 
secretion is decreased during hypoxia, low oxygen actually upregulates overall 
protein secretion in adipocytes, specifically inflammatory cytokines (TNFα, Il-6) 
and leptin (Chen et al., 2006; Grosfeld et al., 2002; He et al., 2014; Magalang et 
al., 2009).  Increased overall protein secretion requires an increase in ER 
chaperone activity and Ero1α, another protein with a similar role in ER disulfide 
bond formation, has been previously shown to be upregulated in the presence of 
hypoxia (Gess et al., 2003; May et al., 2005). Adrx is upregulated in parallel with 
Ero1α and may have a similar function.   
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Stabilized HIF1 but not Nrf2 stimulates Adrx expression 
 The hypoxia–mediated response is mainly regulated by the hypoxia-
inducible factor (HIF) family of proteins, a class of heterodimeric transcription 
factors (Semenza, 2000). Cytotoxic reactive oxygen species are also generated 
during hypoxia and initiate a secondary antioxidant response through nuclear 
factor erythroid 2-related factor 2 (Nrf2) binding to the Antioxidant Response 
Element (ARE). The transcription factor binding site prediction program 
MatInspector identified both a HIF Response Element and ARE in the promoter 
of Adrx (Cartharius et al., 2005).  To examine whether HIF or Nrf2 regulates 
Adrx, we tested the effect of hypoxia mimetic compounds, dimethyloxallyl glycine 
(DMOG) and cobalt chloride (CoCl2) and Nrf2 activators bardoxalone, and 
sulforaphane. DMOG is a prolyl hydroxylase inhibitor that can block the 
hydroxylation and degradation of HIF-1α independent of oxygen tension.  Neither 
bardoxalone nor sulforaphane increased Adrx expression after 18 hours (data not 
shown), at the mRNA or protein level. Treatment of 3T3-L1 adipocytes with CoCl2 
or DMOG for 6 and 18 hours upregulated Adiporedoxin mRNA as well as several 
known hypoxia-inducible genes including Ero1α and GLUT1, but had no effect on 
adiponectin expression (Figure 3.2), consistent with published studies (Chen et 
al., 2006). The magnitude of these DMOG-induced changes, combined with the 
presence of multiple HREs in the Adiporedoxin promoter, suggests that the HIF-
1α pathway is a key regulator of Adrx expression.  
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Adiporedoxin protects 3T3-L1s from oxidative stress during hypoxia 
 Ero1a is upregulated during hypoxia and supports the increased secretory 
function of adipocytes during oxidative stress (May et al., 2005). We 
hypothesized that Adrx is upregulated in response to oxidative stress to protect 
cells to maintain protein secretion.  We overexpressed Adrx in 3T3-L1 adipocytes 
and exposed these cells to acute hypoxia (Figure 3.3 A). To assess the degree of 
oxidative stress experienced by the cells, we measured Adpn secretion, an 
indicator of overall adipocyte function as well as ER oxidative folding. In control 
cells, Adrx increased over 8 hours of exposure to 1% O2, peaking at 4 hours 
(Figure 3.3 B-C). Overexpressed Adrx, without an intact promoter, would not be 
expected to increase under these conditions.   
 Adiponectin secretion was impaired by 60% in control cells after 4 hours of 
hypoxia, consistent with the literature and confirming oxidative stress in the cells 
(Fig 3.3 B-C) (Chen et al., 2006). In contrast, cells overexpressing Adrx had a 
25% decrease in secretion. The overexpression of Adrx clearly affects ER 
function, rescuing the negative effects of hypoxia on protein secretion and 
mediating ER stress.   
We used shRNA targeting Adrx to make a stable 3T3-L1 cell line with Adrx 
knocked down almost entirely. Knock down cells exhibited impaired Adpn 
secretion and did not show any further decline during hypoxia (data not shown).  
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Adiporedoxin acts as an antioxidant through peroxidase activity 
Because Adrx is expressed in fully differentiated adipocytes and 
adiponectin is also induced during adipocyte differentiation, we wanted to ensure 
the overexpression of Adrx was not rescuing Adpn secretion through increased 
adipogenesis. Common markers of adipogenesis including PPARy and aP2 
(FABP4) are not increased by the overexpression of Adrx (Figure 3.4 A), nor are 
they decreased with Adrx knock down (data not shown). More importantly, Ero1a, 
which is also enriched in differentiated adipocytes and has been shown to 
mediate protein secretion and oxidative stress, was not significantly changed in 
gain and loss of function cell lines (Gess et al., 2003).  Cellular Adpn levels were 
decreased in the overexpressing cells, consistent with elevated protein secretion 
(Fig 3.4 A).   
Lack of oxygen creates oxidative stress through many pathways, one 
being the generation of ROS (Kim et al., 2011).  The predicted structure of Adrx 
is closely aligned to that of peroxiredoxins and glutathione peroxidases which 
both reduce hydrogen peroxides and other forms of ROS (Dayer et al., 2008). 
This classification, combined with Adrx’s ability to dampen hypoxic stress, 
suggests that Adrx may function as a peroxiredoxin or glutathione peroxidase.  
Addition of external hydrogen peroxide (H2O2) directly oxidizes 
peroxiredoxin 4 (Prdx4) and other H2O2-dependent peroxidases, generating a 
more oxidizing environment in the ER as these peroxidases pass disulfide bonds 
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on to downstream chaperones (Sato et al., 2013). To determine if Adrx changes 
oxidation states in the presence of H2O2, we used PEGylation reagents to identify 
changes in the oxidation state of ER proteins. This reagent covalently reacts with 
reduced cysteines and retards protein mobility by about 2 kDa/cysteine when 
analyzed by non-reducing SDS-PAGE. Fat cells were exposed to increasing 
doses of H2O2 for 10 minutes before being lysed in TCA to preserve disulfides. 
Adrx shifted to a more oxidized state with increasing doses of peroxide along with 
similar changes in the oxidation state of PDI (Figure 3.4 B-C). This suggests that 
Adrx is oxidized by H2O2 as a source of disulfide bonds either by directly reducing 
it, similar to a peroxiredoxin/glutathione peroxidase, or as a downstream 
substrate for a peroxiredoxin/glutation peroxidase. 
We further confirmed peroxidase activity in vitro using a FOX 
assay(DeLong et al., 2002). Peroxides spontaneously oxidize Fe(II) to Fe(III); in 
the FOX assay, xylenol orange forms a complex with Fe(III) to generate a color 
around wavelength 560nm.  In the presence of peroxidase, enzymes peroxides 
are reduced to H2O and cannot oxidize Fe(II), leading to decreased color. We 
previously defined Adrx as a redox protein with a dual cysteine active site 
capable of alternating between an oxidized and reduced form in response to the 
immediate redox environment (Chapter 2). Recombinant Adrx maintains this 
redox function in vitro and can be oxidized or reduced by strong oxidizing or 
reducing agents (Figure 3.4 D). When fully reduced Adrx is added to the FOX 
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system, Adrx acts as a peroxidase and H2O2 is rapidly reduced by 80% within 10 
minutes and by 100% after 20 minutes. In comparison, DTT alone showed no 
reduction in H2O2 (Figure 3.4 E).  
Decreased secretion and oxidative stress from hypoxia is caused by an 
increase in ROS 
 As stated previously, hypoxia induces stress through multiple signaling 
pathways including, but not limited to, ROS.  To determine if hypoxia regulates 
Adrx expression and protein secretion through ROS, we treated 3T3-L1s with 
menadione to generate intracellular ROS independent of a change in oxygen 
tension.  3T3-L1 adipocytes treated with 5mM menadione secreted significantly 
less Adpn and also had upregulated Adpn secretion similar to hypoxic conditions 
(Figure 3.5 A-C).  Menadione’s ability to induce the same level of oxidative stress 
as measured by impaired ER function, without the contribution of other hypoxia-
activated pathways suggests that hypoxia impairs protein secretion and 
upregulates Adrx expression through ROS.   
Because Adrx acts as a peroxidase, we hypothesized that its protective 
action during hypoxia was also due to antioxidant activity.  To test this, we 
treated control and Adrx overexpressing cells with menadione.  Overexpression 
of Adrx rescues 3T3-L1 cells from oxidative stress during menadione treatment; 
Adpn secretion was impaired by 43% in control cells compared with just 13% in 
cells over expressing Adrx (Figure 3.5 D-F).   
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Adrx upregulated in mice during HFD induced oxidative stress 
 While chronic high fat diet is often used to induce obesity first followed by 
a subsequent metabolic decline, signs of compromised metabolic function occur 
with acute high fat feeding well before adiposity increases.  After 3-4 days of high 
fat HFD, glucose intolerance, hepatic insulin resistance, and hepatic steatosis are 
already well established without a significant change in adipose tissue size 
(Barzel et al., 2014; Wiedemann et al., 2013). These early but significant effects 
are most likely attributed to adipocyte dysfunction and inflammation, mediated by 
adipose tissue hypoxia and oxidative stress (Lee et al., 2014; Shin et al., 2012).  
When we challenged mice with 3 days of HFD, HIF-1α was upregulated in 
adipose tissue, indicating that oxidative stress preceded obesity (Figure 3.6 A).  
Not surprisingly, Adrx is also upregulated under these conditions, possibly to 
mediate the negative effects of oxidative stress in adipose tissue.   
Discussion: 
 
Adrx is an ER redox protein, which is expressed in adipocytes and 
regulates secretion. Here we show that Adrx also plays a crucial role in the 
cellular response to oxidative stress. We focused on hypoxia due to its 
physiological relevance to adipose tissue oxidative stress.  
We found that exposure to 1%O2 conditions were sufficient to induce 
oxidative stress and inhibit protein secretion, consistent with published studies 
(Chen et al., 2006; He et al., 2014; Magalang et al., 2009). To mediate this 
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stress, after acute exposure to 1%O2 conditions, Adrx expression is upregulated. 
This is induced, at least partially, through the transcription factor HIF1. Changes 
in oxygen tension stabilize the alpha subunit of HIF1, which translocates to the 
nucleus and enhances the expression of antioxidants and other genes. Using 
CoCl2 to stabilize HIF1a, independent of hypoxia, we show that Adrx expression 
is regulated by HIF1. We did not see a change in Adrx expression after treatment 
with Nrf2 activators, the classic antioxidant response pathway. However, both 
hypoxia and ROS accumulation trigger HIF1 activity, and the observed 
upregulation of Adrx with menadione treatment may be through ROS-activated 
HIF1 activity.  
While this upregulation of Adrx was not sustained, possibly due to cell 
damage after 24 hours, Adrx is clearly protects protein secretion during oxidative 
stress. In monocytes Adrx (called PAMM) has a similar function, overexpression 
protected cells from oxidative stress and impaired osteoclast differentiation (Xu et 
al., 2010). A previous study determined hypoxia and ROS inhibit adiponectin 
secretion through different mechanisms, attributing hypoxic affects to HIF1 and 
ROS signaling to PPARy (Chen et al., 2006). However, our data makes this 
situation more complex. We also see similar impairment of Adpn secretion with 
either hypoxia or ROS accumulation, but both conditions of oxidative stress were 
reversed by the overexpression of Adrx (Figure 3.3 and 3.4). As we 
demonstrated, Adrx does not have any influence over expression of PPARy or 
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adipogenic genes.  Instead, it acts as an antioxidant and redox chaperone. Either 
hypoxia and ROS inhibit Adpn secretion through the same mechanism, or Adrx is 
acting on a separate regulatory step where both pathways converge.  
Given these data, and the results of a previous study, Adrx behaves 
similarly to peroxiredoxins (Prx) and glutathione peroxidases (GPx) (Xu et al., 
2010). Prx 1, 2, 3, and 6, are upregulated in response to hypoxia or ischemic 
injury and the overexpression of Prx 3 and 6 protect various cell types from 
hypoxia induced damage and apoptosis (Chowdhury et al., 2009; Cox et al., 
2010; Jarvis et al., 2012; Kim et al., 2007b). Peroxiredoxins do not contain a 
CxxC domain but typically function as a higher molecular weight complex, which 
brings active site cysteines, well separated in the sequence, into proximity of 
each other. Adrx contains sequential active site cysteines in a PDI-like CxxC 
domain.  
When the first ER resident peroxiredoxin, Peroxiredoxin 4 (Prdx4), was 
discovered, it introduced the concept of peroxiredoxin redox coupling in oxidative 
folding (Zito et al., 2010b). Prdx4 functionally overlaps with Ero1a as a reoxidizer 
of PDIs and master regulator of oxidative folding in secreted proteins (Zito, 2013). 
Our previous paper indicates Adrx has a similar role, and may augment for the 
high secretory activity specific to adipocytes and protect against oxidative stress 
(Chapter 2). Combined with this recent data, we now believe Adrx to be a second 
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ER resident peroxiredoxin or glutathione peroxidase, and an important regulator 
of both protein folding and oxidative stress.  
Methods: 
 
Gel Electrophoresis and Immunoblotting. Gel electrophoresis and 
immunoblotting as previously described in Chapter 2. Antibodies to additional 
proteins were from the following sources ERo1-α (Abnova, Taiwan); IRAP (21st 
Centruy Biochemical, Hopkinton, MA); BiP, Erp44 (Cell Signaling, Beverly, MA); 
Actin (Signma, St. Louis, MO). Antibodies to the following were generous gifts: 
aP2 (Dr. David Bernlohr, University of Minnesota).  
Cell Culture.  Murine 3T3-L1 cells were cultured, differentiated, and maintained 
as described previously in Chapter 2.  
Quantitative Real-time PCR. Total RNA was collected and purified using 
RNeasy Mini Prep Kit (Qiagen). cDNA synthesis was performed using 1 μg RNA 
and iScript cDNA synthesis kit (Bio-Rad) according to manufacturer's protocol. 
Quantitative real-time PCR (qPCR) was performed using Fast SYBR green 
enzyme (Applied Biosystems) and measured on ViiA 7 real-time PCR system 
(Applied Biosystems). Transcript levels were analyzed using the ΔΔCt method 
and normalized to Gusb. Primers used are as follows. 
Adpn 5’ GAGAAGGGAGAGAAAGGAAATG  – 3’ (forward) and  
3’ – TGAGCGATACACATAAGCCG – 5’ (reverse)  
Adrx 5’ – AAAGAACCAAGGACATTCAAAGC  – 3’ (forward) and  
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3’ – ACACCTAGCTCATCCAACTG – 5’ (reverse)  
BiP 5’ – TTCAGCCAATTATCAGCAACTCT  – 3’ (forward) and  
5’ – TTTTCTGATATCCTCTTACCAGT – 3’ (reverse)  
GLUT1 5’ – CAGTTCGGCTATAACACTGGTG  – 3’ (forward) and  
5’ – GCCCCCGACAGAGAAGATG – 3’ (reverse)  
Gusb 5’ CACCCCTACCACTTACATC  – 3’ (forward) and  
5’ – ACTTTGCCACCCTCATCC – 3’ (reverse)  
Ero1a 5’ TTCTGCCAGGTTAGTGGTTACC  – 3’ (forward) and  
5’ – GTTTGACGGCACAGTCTCTTC – 3’ (reverse)  
Recombinant Adrx PEGylation 
The Mus Musculus Adrx cDNA without the signal sequence (aa: 31-218) was 
amplified from total 3T3-L1 cDNA by using specific primers, which contain 
the NdeI and BamHI restriction sites  
(Forward:5’-GGGAATTCCATATGCGAAAAGCAGCACTGGAATATTTG-3’; 
Reverse: 5’-TTCGGATCCATTTCAGCTTCTCCCGGACGC-3’).  
The PCR product was cloned into plasmid pET15b (kindly provided by Valentina 
Perrissi), generating an N-terminal fusion to the 6xHis-Tag sequence from the 
vector. Fusion protein was expressed in E. Coli BL21 followed by Ni-NTA affinity 
chromatography. Recombinant protein was dialyzed and concentrated by using 
Vivaspin 6. Final concentration was determined by Bradford method. 
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100 μM of recombinant Adrx protein was incubated with either 2 M DTT or 1 M 
diamide on ice for 30 minutes. At the end of incubation the reaction was desalted 
on PD G-25 column and flow through was collected immediately added to 
PEGylation reagent (described Chapter 2). 
Ferrous Oxidation-Xylenol orange (FOX) Assay   
10 mM of reduced (desalted) protein  and 100 mM DTT were mixed in 50 mM 
potassium phosphate buffer pH 7.0 at room temperature. The reaction was 
initiated by the addition of 100 mM hydrogen peroxide (H2O2) with and without 
5μM recombinant Adrx. The concentration of remaining hydrogen peroxide was 
determined at various time points up to 120 min by a xylenol orange-iron 
reaction. Briefly, 40 μl of the reaction was removed from the reaction mixture and 
added to 400 μl of FOX reagent (250 μM ammonium ferrous sulfate, 125 μM 
xylenol orange, 100 mM sorbitol, and 25 mM sulfuric acid). The FOX mixture was 
incubated for 30 min at room temperature and the absorbance at 560 nm was 
then monitored. Residual H2O2 concentration in the reaction was calculated using 
a standard curve. The assay was performed in triplicate. 
Animals  
Animals were generated and housed as previously described in Chapter 2. For 
HFD study, mice were subjected to HFD (45% calories, mainly as lard) or NC 
diets (10% of calories from fat) for the indicated time periods (Research Diets, 
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Inc; USA). Animal tissue was collected and analyzed as previously described in 
Chapter 2.  
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Figure 3.1 Time dependent effects of hypoxia on Adrx expression. 
(A) Fully differentiated 3T3-L1 adipocytes were treated with Thapsigargen, 
Tunicamycin, or N-acetylcysteine, or exposed to hypoxia for 24 hours. Cells were 
then lysed and protein was assessed by SDS-PAGE. (B-C) Fully differentiated 
3T3-L1 adipocytes were cultured in normoxia or 1% O2 (hypoxia) for 2, 4, 8, or 24 
hours. Cells were then lysed and protein was assessed by SDS-PAGE. (D) 
Protein immunoblots were quantified relative to βactin using a Fujifilm LAS-4000 
scanner. Adrx quantification was normalized to actin. Data presented are 
representative of three separate experiments. 
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Figure 3.2 HIF1a stabilizers enhance Adrx expression. 
Fully differentiated 3T3-L1 cells were exposed to 200μM of CoCl2 or 0.5mM 
DMOG for 18 hours. Total RNA extracted from the cells was subjected to 
quantitative real-time PCR to determine relative mRNA abundance of Adrx 
mRNA (n=4 experiments, p < 0.05 DMOG vs. Control) 
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Figure 3.3 Adrx rescues adiponectin secretion during hypoxia induced ER 
stress. 
 (A-B) Fully differentiated 3T3-L1 cells infected with vector (+pBabe) or Adrx 
(+Adrx) were cultured in serum free DMEM in 1%O2 hypoxia for 0, 2, 4, or 8 
hours. Cells were then lysed and protein was assessed by SDS-PAGE. 
Conditioned media was collected after 8 hours and assessed by SDS-PAGE. (C) 
Immunoblots of secreted Adpn were quantified using Fujifilm LAS-4000 scanner 
(n=3 experiments, p < 0.05). 
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Figure 3.4 Adrx does not influence adipokines through adipogenesis and 
Adrx has peroxidase activity.  
 (A) 3T3-L1s over expressing Adrx or empty pBabe vector were induced to 
differentiate on day 0. Plates were lysed at day 0, 2, 4, 6, and 8 when cells were 
fully differentiated. Protein was assessed by SDS-PAGE and expression of Adrx 
and markers of adipogenesis, Pparg, ap2, Adiponectin, Ero1a was measured 
(n=2). (B) 3T3-L1 cells were treated with various concentrations of H2O2 for 5 
min., lysed with 20% TCA, and TCA precipitates were reacted with MalPEG-2K 
to modify free cysteines. Adrx and protein disulfide isomerase a1 (PDIa1) were 
visualized by immunoblotting following native gel electrophoresis of the TCA 
precipitates (C) and quantified. (n=3 experiments p < 0.02 vs. Control) (D) 
Purified recombinant Adrx protein treated with DTT or Diamide was reacted with 
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MalPEG-2K and assessed by immunobloting for Adrx. (E) FOX assay for 
reduction of H2O2 in the presence of recombinant Adrx (p < 0.05).  
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Figure 3.5 Effects of menadione on Adrx and Adpn secretion. 
(A-C) Fully differentiated 3T3-L1 or (D-F) 3T3-L1 stably expressing vector 
(+pBabe) or Adrx (+Adrx) were cultured in serum free DMEM with or without 1μM 
menadione for 1, 4, or 8 hours. Cells were then lysed and protein was assessed 
by SDS-PAGE. Conditioned media was collected after 8 hours and assessed by 
SDS-PAGE. Immunoblots of secreted Adpn were quantified using Fujifilm LAS-
4000 scanner (n=4 experiments, p < 0.05).  
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Figure 3.6 Increased Adrx in response to oxidative stress in vivo. 
(A) Western blot of HIF1 and Adrx in epididymal fat pads from mice fed normal 
chow diet (NC) or HFD for 3 days 8-week-old strain-matched males were used  
n=2. 
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Introduction: 
 
 Insulin is a metabolic hormone secreted by pancreatic β-cells after a meal. 
Proper secretion of insulin is crucial for systemic glucose metabolism and the 
identification and purification of insulin for the treatment of diabetes is still 
considered one of the biggest discoveries in medicine (Rosenfeld, 2002). Mature 
insulin has a disulfide-bonded structure and newly translated insulin (proinsulin) 
in the ER must undergo oxidative folding and modifications before being 
trafficked to the Golgi for secretion. Three disulfide bonds hold together the three 
dimensional structure of insulin, one within the A chain, and two connecting the A 
and B chains (Goodge and Hutton, 2000).  The formation of these disulfide bonds 
is attributed to the action of a large family of PDIs, which are reoxidized, by the 
Ero-1 family of oxidoreductases or by peroxiredoxin 4 (Prdx4) (Rajpal et al., 
2012). The extremely high protein folding load and importance of this pathway in 
β-cells is reflected in the tissue specific expression of a second isoform of Ero1, 
Ero1β (Rajpal et al., 2012; Zito et al., 2010a). For each disulfide bond formed 
through Ero-1 oxidoreductases a stoichiometric equivalent amount of H2O2 is also 
generated, and it is estimated this process contributes 25% of total cellular ROS 
(Tu and Weissman, 2004). Pancreatic β-cells are especially susceptible to ROS 
induced oxidative stress due to very low expression of antioxidant enzymes such 
as catalase. This is especially true in the ER, which contains only three known 
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antioxidant enzymes: Glutathione peroxidase 7 (GPx7), GPx8, and Prdx4 
(Lenzen et al., 1996; Ramming and Appenzeller-Herzog, 2013). 
 Low levels of antioxidant enzymes also sensitize β-cells to the signaling 
action of ROS. ROS are generated at significant steps during glucose stimulated 
insulin secretion, including increased fuel availability, low ADP levels, and 
increased Ca2+ concentrations. Other regulatory steps are down stream targets 
of ROS including voltage gated KATP channels, Ca2+ channels, and protein 
phosphatases and kinases involved in exocytosis (Fu et al., 2013). Increased 
intracellular ROS, whether from fatty acid accumulation or exogenous H2O2, 
stimulates insulin secretion and an increase in endogenous or exogenous 
antioxidants inhibit glucose stimulated insulin secretion (GSIS) (Saadeh et al., 
2012). However, too much ROS causes oxidative stress, which also inhibits GSIS 
(Pi et al., 2007; Saadeh et al., 2012).  
 Previously, our lab and others identified an ER resident thioredoxin protein 
in adipocytes and bone, named Adiporedoxin (Adrx) that has the ability to 
influence redox homeostasis and protein secretion in adipocytes (Chapter 2) (Xu 
et al., 2010). Here we explore the expression of Adrx in islets, another highly 
secretory organ dependent on proper redox homeostasis for function.  
Results: 
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Adrx KO mice islets decreases insulin secretion and increases retention 
 Adrx, an ER redox protein, was previously shown to regulate global 
protein secretion in adipocytes (Chapter 2) and it affects the redox state of 
osteoblasts (Xu et al., 2010). Although Adrx is highly expressed in fat, we 
hypothesized that it also acts in other endocrine cell types. Pancreatic islets are 
highly secretory and require tight redox regulation in the ER for the secretion of 
insulin (Lenzen et al., 1996). Our lab (Dr. Libin Liu) generated an Adrx KO mouse 
and some characteristics have been described previously (Chapter 2). Islets 
were isolated from Adrx KO mice and wild-type littermates and assayed for 
insulin content and secretion during perifusion. Isolated islet content was 
assessed immediately following isolation and after 24 hours in culture leading up 
to perifusion studies. At both time points, content was slightly higher in KO mice 
compared to wild-type (Figure 4.4 A). The accumulation of intracellular insulin 
either resulted from increased insulin biosynthesis or compromised secretion. To 
understand whether the loss of Adrx impaired insulin secretion, we performed 
perifusion studies at low (3.3mM) and high (16.7mM) glucose. At both glucose 
concentrations, insulin release was decreased in islets from Adrx KO mice when 
compared with wild-type mice (Figure 4.4 B). This was amplified when insulin 
secretion was expressed as a percentage of insulin content, indicated by a 
significant decrease in stimulated insulin release from Adrx KO islets when 
compared to wild type. 
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Adrx is found in pancreatic islets 
 Western blots of the intact pancreas do not show Adrx protein expression, 
at least relative to adipose tissue, but pancreatic islets only comprise 1-2% of the 
pancreas and may not be well represented in whole pancreas blots (Chapter 2). 
Immunostaining of isolated islets indicate the expression of a small amount of 
Adrx protein, although still lower than Adrx in 3T3-L1 adipocyte controls (Figure 
4.1 A). However, this is not surprising since islets are known to have 
considerably lower levels of antioxidant enzymes in general – containing only 1% 
catalase activity, 2% GPX1 activity, and 29% SOD activity when compared to 
liver (Lei and Vatamaniuk, 2011). Although it is difficult to assess protein in islets 
due to their small volume relative to the rest of the pancreas, using qtPCR we 
detected a CT value of 26.1 in isolated mouse islets suggesting significant levels 
of expression. Islets from Adrx KO mice showed no Adrx message as expected, 
and Adrx message was decreased by 40% in heterozygous mice (Figure 4.1 B).  
Adrx acts as an antioxidant  
Lack of oxygen creates oxidative stress through many pathways, one 
being the generation of reactive oxygen species (ROS) (Kim et al., 2011).  The 
predicted structure of Adrx aligns it closely to peroxiredoxins and glutathione 
peroxidases which among other functions, both reduce hydrogen peroxides and 
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other forms of ROS (Dayer et al., 2008). This classification combined with Adrx’s 
ability to alleviate hypoxic stress in the adipocyte, suggested Adrx may function 
as an antioxidant (Chapter 3).  To assess whether Adrx affects ROS in insulin-
secreting cells, we expressed Adrx in INS-1 cultured beta cells. INS-1 cells are 
highly secretory with a complex ER but do not express endogenous Adrx (Figure 
4.2 A).  Under basal conditions the overexpression of Adrx acted as a significant 
antioxidant and cells overexpressing Adrx showed less intracellular ROS (Figure 
4.2 B). When challenged with menadione, a compound that produces intracellular 
ROS, cells overexpressing Adrx showed lover ROS levels overall and also a 
smaller fold change(Fig). This suggests Adrx acts as a protective antioxidant in 
beta cells in response to general increases in ROS and oxidative stress.  
Overexpression of Adrx increases insulin secretion 
The relationship between ROS, antioxidants, and insulin secretion in beta 
cells is complex. Increased ROS is known to stimulate insulin secretion and the 
expression of antioxidants blunts this effect. However, beta cells are also highly 
sensitive to oxidative stress and the induction of antioxidants minimizes cell 
death and stress-impairment of secretion (Pi et al., 2010). Understanding that 
Adrx acts as an antioxidant in INS-1 cells, we next investigated the effects of 
Adrx overexpression on insulin secretion.  We exposed INS-1 cells to three 
conditions, basal (low glucose), high glucose, and high glucose with diazoxide, 
an inhibitor of Ca2+ influx required for vesicle membrane fusion and then 
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assessed insulin secretion of control and cells overexpressing Adrx. All cells 
responded to high glucose stimulations with a 2-3 fold increase in insulin 
secretion compared to basal conditions, similar to published studies (Pi et al., 
2007). In cells expressing Adrx there was a significant increase in insulin 
secretion at basal conditions as compared with control cells and this affect 
continued during glucose stimulation (Figure 4.2 B). Adrx expression also 
maintained higher insulin secretion when glucose stimulated vesicular trafficking 
was inhibited with diazoxide. The consistent increase in insulin secretion across 
all conditions suggests Adrx expression upregulates insulin secretion 
independent of glucose stimulation or Ca2+ dependent vesicular trafficking. While 
stimulated insulin secretion is well studied, the mechanisms regulating basal 
secretion are relatively unknown. The presence of multiple disulfide bonds in the 
structure of mature insulin suggests Adrx may influence secretion by regulating 
oxidative folding or ER redox homeostasis, upstream of glucose stimulation.   
Antioxidant action alone does not increase insulin secretion in INS-1 cells 
 To determine whether the antioxidant activity of Adrx alone is responsible 
for increased insulin secretion, we treated INS-1 cells with low levels of the 
antioxidant N-acetyl cysteine (NAC) (0.375 or 0.75mM). The insulin content was 
assessed in both control cells and cells treated with NAC for 72 hours. Insulin 
content was significantly higher after antioxidant exposure, consistent with Adrx 
overexpression (Figure 4.3 B). However, with antioxidants alone, the increase in 
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content did not translate to higher secretion (Figure 4.3 A). Glucose was still able 
to stimulate insulin secretion in NAC treated cells, but at each concentration, 
insulin secretion was actually lower after exposure to antioxidants. While the 
general antioxidant effect of Adrx may partially contribute to insulin biosynthesis, 
Adrx must be upregulating insulin secretion through a different mechanism. 
 
Discussion: 
 
 Pancreatic islets and adipocytes are both endocrine tissues with high 
secretory functions. It is not surprising then, that Adrx is also expressed in 
pancreatic islets, where the demand for oxidative folding already necessitates a 
second isoform of Ero1 (Zito et al., 2010a). Our data on Adrx action in the beta 
cell is similar to our previous studies on the adipocyte (Chapter 2). Adrx 
overexpression increases basal insulin secretion, independent of glucose 
stimulation or vesicular trafficking. Similarly, global loss of Adrx mice causes 
increased insulin content as well as impaired insulin secretion in isolated islets at 
both basal and high glucose conditions. While these data do not provide a 
mechanism for how Adrx regulates insulin secretion, it tells us quite a bit about 
what is not occurring. Adrx does not primarily effect those pathways implicated in 
glucose stimulated insulin secretion (GSIS), because both basal and GSIS are 
similarly affected by Adrx alteration. Intracellular Ca2+ is a second regulatory point 
for insulin secretion and is similarly unaffected with Adrx expression. Although an 
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increase in insulin synthesis could explain this trend, islets lacking Adrx have 
higher insulin content than WT littermates. If Adrx was directly regulating de novo 
protein synthesis, we would expect insulin content to be down in KO mice.  
 When expressed in INS-1 cells, Adrx acts as an antioxidant, consistent 
with previous studies in adipocytes and monocytes (Xu et al., 2010). The 
pancreas has relatively few antioxidant enzymes and insulin secretion, among 
other cellular processes, is sensitive to changes in ROS (Lei and Vatamaniuk, 
2011). The overexpression of ER targeted antioxidant Prdx4 in INS-1 cells 
increased insulin content and improved insulin secretion, although only during 
glucose stimulation (Ding et al., 2010; Mehmeti et al., 2014). And knockdown of 
other antioxidant enzymes in the pancreas or beta cell also impairs insulin 
release from isolate islets, as seen with GPX-/- and SOD-/- mice (Wang et al., 
2011). In our INS-1 studies, chronic culture with antioxidants upregulated insulin 
content but did not increase insulin secretion.  While Adrx may act as an 
antioxidant, this action is not exclusively responsible for the observed increase in 
secretion. Both Prdx4 and Adrx are ER resident and this compartmentalized 
location may explain the differential effect. During insulin folding, Ero1 
oxidoreductases generate copious amounts of H2O2 in the ER and targeted 
antioxidant activity could mediate this specific source of ROS to prevent protein 
misfolding and ER stress.  
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It is likely that Adrx not only neutralizes ROS, but also utilizes the transfer 
of electrons to H2O2 to improve oxidative folding, leading to less protein 
degradation and more secretion.  In adipocytes, we showed Adrx regulates redox 
homeostasis and we hypothesize a similar influence of Adrx in the beta cell 
(Chapter 2). The oxidative folding machinery in beta cells is required for the high 
insulin synthesis rate. Such a high rate of synthesis can lead to an accumulation 
of misfolded pro-insulin in the ER, and necessitates the second, pancreas-
specific isoform of Ero1. Adrx action in the beta cell ER would allow for an 
additional oxidative chaperone and consequently, ER folding activity, presumably 
leading to greater insulin secretion. Interestingly an increase in proinsulin/insulin 
ration is observed in T2D, implying an important role of insulin folding in the 
pathology of diabetes (Roder et al., 1998). 
In conclusion, Adrx regulates insulin secretion in isolated pancreatic islets 
and cultured beta cells similar to its actions in adipocytes. While Adrx certainly 
acts as an antioxidant, this is not the main mechanism by which it influences 
protein secretion. Further experiments are needed to investigate how Adrx 
influences the sensitive redox state of the beta cell, in particular whether the 
overexpression of Adrx in INS1 cells changes insulin content and if antioxidant 
activity is confined to the ER. 
Methods: 
 
Cell Culture 
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INS-1 832/13 cells were cultured in RPMI media with the addition of 10 mM 
Hepes, 1 mM sodium pyruvate, 0.4 mM glutamine and 50 µM ß-mercaptoethanol 
(Hohmeier et al., 2000). ß-Mercaptoethanol was routinely added to the RPMI 
media just before use. Transient transfections were done using Mirus TransIT 
(Madison, WI) 1 day before INS-1 cells were seeded into 96 well plates for insulin 
and ROS assays.  
Insulin content and secretion assay 
INS-1 cells in 96 well plates were incubated in RPMI with 2mM glucose (no FBS) 
for 2 hours. Then cells were incubated with 2 mM glucose Krebs Ringer buffer 
supplemented with 2 mM Ca2+ with 0.05% FA-free BSA for 30 minutes. Plates 
were changed to 125 μl of fresh Krebs Ringer with either 2 or 8 mM glucose in 
Krebs Ringer and incubated in a 37° water bath for 2 hours. Cells were lysed with 
0.1% triton and 25mM NaOH in PBS buffer. Insulin was assessed by Cisbio 
HTRF Insulin Assay kit (Bedford, MA). 
ROS determination 
Cells were loaded for 45 min with 8 µM 5-(and-6)-chloromethyl-2′,7′-
dichlorodihydrofluorescein diacetate, acetyl ester (CM-H2DCFDA) suspended in 
KRB containing 0.1% pleuronic acid, followed by two 15 min washes in KRB. 
DCF fluorescence was then measured over time using a TECAN M 1000 plate 
reader (Mannedorf, Switzerland) (excitation at 488 nm; emission at 520 nm). 
Islet perifusion 
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Islets were isolated via perfusion of the pancreas with 1mg/ml collagenase and 
cultured in RPMI without FBS. 12 islets from each of 6 male mice (3 WT and 3 
KO) were lysed in two groups on the same day as isolation and assed for insulin 
content as stated above.  The islets were rested overnight in RPMI supplemented 
with 10mM HEPES, 0.2mM glutamine, and 10% FBS.  30 - 50 islets of similar 
size were preincubated with 2.8mM glucose and then perifused for 30 minutes 
with first 2.8 mM glucose and 16.7mM glucose at a rate of 0.3 mls/minute. 
Secretion was normalized per/islet.  
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Figure 4.1 Islets from Adrx null mice have increased insulin content and 
decreased glucose stimulated release. 
(A) Insulin content from isolated islets compared between 8-week-old strain-
matched male littermates. (n=2, error bars represent SE) (B) Islets from 8-week-
old strain matched males were perifused at basal (2.8 mM)  and high glucose 
(16.7mM) for 30 minutes in room temperature at a rate of 0.3 mls/minute. Lines 
are a 4-point running average fit to data points. Secretion was normalized 
per/islet. (n=3, p<0.05, error bars represents SD)              
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Figure 4.2 Adrx expression in pancreatic islets. 
(A) Adrx mRNA from isolated islets compared between litermates. (n=3 animals 
/group, error bars represent SD, p < =0.05) (B) Isolated islets from multiple mice 
were lysed for protein and assessed for Adrx protein through SDS-PAGE 
alongside a 3T3-L1 adipocyte positive control.  
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Figure 4.3 Adrx expression increases insulin secretion in INS-1 beta cells. 
(A) INS-1 cultured beta cells were transiently transfected with Adrx or empty 
pcDNA vector. (B) Adrx transfection increased insulin release under basal (2mM 
glucose), glucose stimulated (8mM glucose), or glucose stimulated plus 
diazoxide (8mM glucose, 0.4mM diazoxide) conditions. (n=8 wells over 2 
experiments, error bars represent SD, p< 0.03) (C) Adrx reduces intracellualar 
ROS. Adrx transfection reduced ROS levels under basal conditions or treated 
with 1μM menadione for 4 hours when compared to vector. Cells were loaded 
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with CM-H2DCFA and read using a Tecan fluorescence platereader. (n=10 wells 
over 2 experiments, error bars represent SD, p <  0.02) 
  
116	
 
 
Figure 4.4 Effects of N-acetylcysteine on insulin secretion and content in 
INS-1 cells. 
(A)INS-1 cells incubated for 72 hours in RPMI supplemented with 11mM glucose 
(G) and either vehicle or low concentrations of N-acetycysteine (NAC). After 72 
hours NAC was washed out and cells were assed for (B) insulin content and (A) 
secretion at increasing concentrations of glucose.  
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CHAPTER 5 
GENERAL DISCUSSION: 
 
Adiporedoxin (Adrx) was previously discovered in adipocytes and shown 
to reside in the ER and correlate with protein secretion. Specifically, 
overexpression of Adrx increases the secretion of adipokines adiponectin (Adpn), 
adipsin, and the insulin receptor (IR) while, knock down of Adrx has the opposite 
effect (Jedrychowski et al., 2010). Metabolic hormones including adipokines and 
insulin control most aspects of metabolism and Adrx expression may be an 
overarching regulator of these hormones and other secreted proteins. However, 
the mechanism behind this relationship was previously unknown. Understanding 
the mechanism by which Adrx effects protein secretion has implications in all 
facets of the metabolic syndrome. In the three chapters of this thesis I describe 
how Adrx influences protein secretion in adipose tissue and pancreatic islets. 
First, I confirm Adrx acts as a redox protein in the lumen of the ER and oscillates 
between a reduced and oxidized form in response to H2O2. Knocking down Adrx 
impaired the reoxidation of PDI under the same conditions, placing Adrx 
upstream intermediate between ER redox chaperones and H2O2 (Chapter 2). 
With the ability to reduce H2O2, I next showed Adrx also maintains protein 
secretion by alleviating oxidative stress from excess ROS or hypoxia (Chapter 3). 
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Finally, I showed Adrx expression in pancreatic islets and similar influence the 
secretion of insulin (Chapter 4). 
Adrx is an ER transmembrane protein with active site in the lumen 
 
Adrx contains a thioredoxin fold and CxxC thioredoxin active site in line 
with members of the thioredoxin (Trx) family. The Trx family is extremely diverse 
and comprised of proteins which catalyze oxidoreductase reactions by a dithiol-
disulfide exchange mechanism usually through two redox-active cysteines 
separated by a pair of amino acids (CxxC motif). The Thioredoxin family includes 
both reductants (Trxs and glutaredoxins (Grxs)), and oxidants (disulfide 
isomerases) often defined by cellular localization; cytoplasmic thioredoxins 
maintain a reducing environment while ER localized disulfide isomerases 
governs protein oxidation (Aslund and Beckwith, 1999; Atkinson and Babbitt, 
2009; Eklund, 1984). 
I performed immunofluorescence co-localization assays and demonstrated 
Adrx localizes almost identically to the ER membrane resident protein, calnexin, 
despite a lack of traditional ER retention motifs (Figure 2.1 D).  Although this is 
uncommon, it is not unprecedented; functionally similar transmembrane 
thioredoxin-related (TMX) proteins are also ER bound without traditional 
retention/recycling motifs (Sugiura et al., 2010). One possible explanation could 
lie in the transmembrane domain itself; core 1 β3GalT specific molecular 
chaperone (Cosmc), a type II ER transmembrane chaperone which is essential 
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for the synthesis of O-glycans, only requires an intact transmembrane domain to 
localize in the ER (Sun et al., 2011b). With Adrx residing in the ER membrane, it 
was important to determine the membrane topology, specifically what side of the 
membrane contained the active site. Using trypsin to digest the external face of 
the ER membrane I clearly defined Adrx as a type II transmembrane protein and 
placed the C-terminus and active site within the lumen of the ER, consistent with 
an oxidant function (Figure 5.1). It is this lumen facing orientation that allows Adrx 
to interact with ER redox chaperones and reduce ER H2O2.  
Adrx active site differentiates it from traditional PDIs 
 
The most abundant thioredoxin family members in the ER are protein 
disulfide isomerases, which oxidize or transfer disulfide bonds to newly 
synthesized secreted and transmembrane proteins. Most ER disulfide isomerase 
chaperones contain a conserved CGHC domain and reside in the lumen, 
retained by an ER retention sequences. This includes the known players in 
oxidative folding and protein secretion, PDI etc. (Appenzeller-Herzog and 
Ellgaard, 2008).  While Adrx has a significant role in protein secretion, its 
predicted structure, membrane localization and unique CFLC active site 
differentiate it from these proteins.   
As stated in the introduction, the residues between the active site 
cysteines play an important role in determining overall redox potential, and must 
be considered when extrapolating protein function.  The highly conserved active 
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site of PDIs (C-G-H-C), and the histidine in particular, is essential to isomerase 
and oxidant function in the ER.  
Strong oxidants, including human PDI (C-G-H-C) and DsbA (C-P-H-C), 
have a redox potential between ΔE’0 =  -122 mV to -175mV (Lundstrom et al., 
1992; Wunderlich et al., 1993) while strong reductants such as bacterial Trx (C-
G-P-C) have a redox potential around ΔE’0 = -270mV(Krause et al., 1991).  
Mutation of the proline to a histidine in Trx, a typical cytosolic reductant, 
increases its standard potential to between ΔE’0 = -235mV and -221mV and 
corresponds to a 10-fold increase in oxidant activity determined by protein folding 
(Krause et al., 1991; Lundstrom et al., 1992). This indicates the importance of the 
residues between the cysteines to thioredoxin redox potential and function. The 
active site of Adrx is unique among thioredoxin proteins (C-F-L-C). In fact, the 
closest overlap is within the second CxxCxxC domain of Ero1a (vgCfkCrl), 
though it is unclear whether this similarity is coincidental.  Currently we known 
the phenylalanine – leucine pairing differentiates Adrx from other ER resident 
PDIs, but the full significance of this sequences remains to be determined. 
Adrx does not participate in thiol mediated retention 
 
 Redox chaperones like the PDIs directly interact with secreted proteins in 
the ER. This interaction leads to a consistent pattern of thiol mediated retention 
and inverse correlation between expression of chaperones and secretion. When 
chaperones are overexpressed protein secretion is reduced and when they are 
121	
knocked down secretion increases. This is demonstrated with Erp44 and PDI. As 
levels of Erp44 are increased, the amount of Adpn secreted is reduced and 3T3-
L1s knocked down for Erp44 have increased Adpn secretion (Wang et al., 2007). 
In beta cells, knocking down PDI also enhances insulin export (Rajpal et al., 
2012). Our data indicates Adrx has the opposite effect – directly correlating with 
secretion in both adipocytes and beta cells.   
Adrx has structural elements of peroxiredoxins and glutathione 
peroxidases 
 
Within the thioredoxin fold, different superfamilies are easily identified by 
unique insertions between the conserved α helixes and β sheets.  When 
categorized by these variations, structural similarity is the best indication of 
overlapping function (Atkinson and Babbitt, 2009).  Glutaredoxins are the most 
true to the thioredoxin fold and they are found as small monomers consisting of 
only the thioredoxin fold domain.  Thioredoxins, including PDIs and cytosolic Trx, 
contain an extra βα domain N-terminally of the thioredoxin fold (Figure 1.3).  
GSTs have an additional α helix domain, this time C-terminal to the thioredoxin 
fold.  Another common variation is the insertion of an extra domain between β2 
and α2.  Glutathione perxoidases and Peroxiredoxins both catalyze the reduction 
of hydrogen peroxide and contain and additional α helix and β strand in this 
position. Modeling Adrx in silico (Figure 1.4) revealed a complex thioredoxin fold 
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with a large insert after α1, not typical to ER PDIs. The insert sequence includes 
an additional α helix and β strand, a modification only found in peroxiredoxins 
and glutathione peroxidases (Kelley and Sternberg, 2009).  
The presence of a cis-proline before the third beta sheet is another highly 
conserved sequence among thioredoxin proteins. Structurally, this residue is 
exposed to solvent within the active site and is important to catalytic activity 
(Charbonnier et al., 1999; Nathaniel et al., 2003). Surprisingly, or not, the region 
between α2 and β3 in Adrx lacks a cis-proline, an adaptation only found in 
glutathione peroxidases. The evolutionary preservation of this domain conveys its 
importance to thioredoxin function, but the exact mechanism by which the 
exposed proline aids redox reactions is not agreed upon.  Several possible 
explanations exist including assistance of the formation of hydrogen bonds 
between protein and substrate and the prevention of metal binding in the active 
site (Martin, 1995; Su et al., 2007). Although we cannot determine what the lack 
of this domain signifies about the function of Adrx, it is a strong indication of 
superfamily.  Structurally, Adrx is much more similar to peroxiredoxins and 
glutathione peroxidases than to PDIs, thioredoxins, or glutaredoxins. While these 
structural clues do not confirm the activity of Adrx, they do indicate a possible 
function, namely reduction of hydrogen peroxides (Martin, 1995).  
Adrx rescues protein secretion during oxidative stress 
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 Confirming the classification as a peroxiredoxin or glutathione peroxidase, 
our lab and others have shown Adrx to have antioxidant activity (Chapters 3,4) 
(Xu et al., 2010). In several cell types the overexpression of Adrx lowers 
intracellular reactive oxygen species during basal conditions and also when 
challenged with a ROS inducer. Extending this to physiological conditions, I 
showed Adrx expression responds to oxidative stress, whether from hypoxia or 
direct induction of ROS, and Adrx protein is upregulated through HIF1 binding.  
Similar to Ero1α, Adrx is likely upregulated to mediate the resulting impairment in 
disulfide bond formation under these conditions. Confirming this, I showed the 
overexpression of Adrx restores protein secretion of adiponectin during oxidative 
stress (Figures 3.3, 3.4). Oxidative and hypoxic stresses occur early in the 
metabolic syndrome and the resulting dysregulation of adipokines perpetuates 
metabolic dysfunction. Increasing Adrx expression and activity is a possible way 
to unlink these two outcomes. 
Adrx impacts protein secretion at the level of oxidative folding in the ER 
 
Hypoxia and ROS impair the secretion of adiponectin at two regulatory 
steps: 1. the down regulation of adiponectin mRNA and 2. disruption of oxidative 
folding in the ER. Other groups have shown hypoxia and ROS act on adiponectin 
transcription through different mechanisms (Chen et al., 2006). However, Adrx 
restores secretion under both conditions, suggesting it must be acting on a 
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common downstream regulatory step (Chen et al., 2006). This step is likely 
oxidative folding in the ER.  
During hypoxia, the ER experiences reduced oxygen, the rate determining 
substrate for Ero1α. This leads to a back up in reduced Ero1α, increased H2O2, 
and decreased overall protein folding (May et al., 2005). An independent 
increase in ROS, from menadione for example, also causes a decrease in protein 
folding. Excess ROS in the ER cause oxidative damage to ER proteins and 
misfolding, requiring multiple isomerase rearrangements and also leading to 
decreased overall folding as chaperones and oxidoreductases are overwhelmed 
(Hetz, 2012).  
  In both situations antioxidant enzymes, such as Adrx or Prdx4, reduce 
ROS and mediate the resulting oxidative stress (Ding et al., 2010). Further, ER 
resident peroxiredoxins and glutathione peroxidases can oxidize PDIs and 
accelerate oxidative folding independent of Ero1α activity. Using PEGylation 
reagents we have shown the dual cysteine active site in Adrx is redox 
responsive, alternating between the oxidized or reduced form depending on the 
redox state of the ER. More importantly, Adrx is oxidized in a dose dependent 
fashion in response to H2O2. Oxidation by, or reduction of H2O2 by Adrx is 
consistent with the antioxidant activity previously described. Like Prdx4 or GPx7, 
Adrx influences the reoxidation of redox chaperones either directly or indirectly 
(Wang et al., 2014a; Zito, 2013). PEGylation assays demonstrate that knocking 
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down or overexpressing Adrx leads to a respective impairment or enhancement 
of PDI oxidation in the presence of H2O2. Either by direct interaction or through 
mediating other redox regulators, Adrx is an intermediate between H2O2 and PDI 
(Figure 5.3).  
Oxidation of ER chaperones regulates protein secretion directly through 
disulfide bond formation  
 
Oxidative folding is a complicated but essential process, demonstrated by 
much functional overlap and compensation between redox proteins. Currently we 
have shown Adrx manipulation affects PDI oxidation and also mediates protein 
secretion, but connecting these events is difficult to prove experimentally. Adpn is 
an ideal secreted protein to study due to both its physiological significance, and 
inter-molecular disulfide bond linked multimers, which are easily separated 
through SDS-PAGE.  In vitro studies show isolated adiponectin self assembles 
into hexamer, octodecamer, and HMW multimers depending on environmental 
reduction potential. Notably, a high reduction potential (oxidizing environment 
similar to native ER) is associated with fast oxidation, increased disulfide linked 
dimers, and an accumulation of trimer and hexamer multimers at the expense of 
the HMW form (Briggs et al., 2009). The resulting trimers or hexamers contained 
free thiols which were irreversibly glutathionylated, inhibiting further incorporation 
in to larger disulfide linked multimers. However, these experiments did not 
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consider the contribution of ER chaperones. Oxidative chaperones form disulfide 
bonds, but also break, and rearranged improperly formed bonds or suboptimal 
glutathionylation (Briggs et al., 2011). Using non-reducing, denaturing SDS-
PAGE we were able to examine the formation of inter-molecular disulfides under 
different redox conditions in intact cells.  
 Impairments in PDI oxidation are most clearly visualized by PEGylation 
under acute stress, before the unfolded protein response and other chaperones 
compensate for the lack of Adrx. However, adiponectin secretion requires an 
extended timeline under basal conditions, outside of the sensitivity of PEGylation 
assays. To get around this, we used a small molecule inhibitor of Ero1α to 
acutely disrupt PDI oxidation and looked at recovery after DTT treatment.  
By Inhibiting Ero1α we saw an overall decrease in adiponectin secretion, 
similar to Adrx knock down cells (Figure 5.4 A).  Treatment with the Ero1a 
inhibitor decreased the oxidation of PDI during basal conditions and also during 
recovery from DTT treatment (Figure 5.4 B,D). Using a denaturing non-reducing 
gel, we were able to separate adiponectin monomers from disulfide bonded 
dimers and directly visualize disulfide bond formation in the ER (Figure 5.4 C). 
Along with less oxidized PDI, treatment with DTT or the Ero1a inhibitor also 
caused a decreased in disulfide bonded adiponectin within the cell. After a DTT 
chase, PDI re-oxidation is delayed by Ero1a inhibition and so is the formation of 
Adpn disulfides. In this system we show an impairment in oxidized PDI directly 
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translates to fewer intra molecular disulfide bonds in ER Adpn, and then a 
decrease in Adpn secretion of all multimers. 
Physiological Significance 
 
 The discovery of an additional ER peroxiredoxin in adipocytes and islets 
highlights the importance of oxidative folding in highly secretory tissues. Proper 
release of adipokines and insulin is crucial to maintain healthy metabolic 
homeostasis. With the expression of Adrx, these tissues have developed 
additional redox proteins to sustain increased oxidative folding. In adipocytes, 
Adrx increases the oxidation of redox chaperone PDI and this leads to increased 
disulfide bond formation in all secreted proteins and overall increased secretion 
(Chapter 2). Adipokines have a wide variety of actions, many improving 
metabolic health but others impairing it (Galic et al., 2010). Adrx apparently acts 
with a non-specific mechanism and regulates the redox status of all disulfide-
bonded proteins equally, including collagen, an important extra cellular matrix 
protein that contributes to adipose tissue fibrosis and dysfunction. This diversity 
leads to a complicated whole body phenotype reflecting the net affect from an 
increase or decrease across all secreted proteins.  
Studying the Adrx null mouse requires a ‘big picture’ view of metabolism 
and an appreciation for the possibly interactions of all secreted factors. Mice with 
decreased Adpn are predisposed to HFD induced obesity, cardiac hypertrophy, 
and impaired insulin sensitivity (Asano et al., 2009; Guo et al., 2013). The loss of 
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Adrx in mice results in less circulating Adpn but this is counter balanced by a 
reduction of fibrosis in adipose tissue, resulting in only a mild metabolic 
phenotype after HFD (Chapter 2). Although Adrx has a direct effect on insulin 
secretion in the beta cell, the pancreas is regulated by external signaling, 
including glucose and other adipokines. Adrx null mice are slightly hyperglycemic 
and also have low levels of leptin, the loss of which is shown to stimulate insulin 
secretion (Lee et al., 2011). This is perhaps why Adrx null mice are slightly 
hyperinsulinemic despite impaired insulin secretion in isolated islets (Chapter 4). 
Future Directions 
  
 While we have focused exclusively on PDI1a, there are many other redox 
chaperones in the adipocyte ER. Expanding our approach to investigate the 
relationship between Adrx and other chaperones may reveal other preferential 
redox partners and substrates. Erp44 is specifically implicated in Adpn folding 
and may interact with Adrx (Otsu et al., 2006). Co-immunoprecipitating Adrx or 
redox chaperones may allow us to identify Adrx substrates/interacting partners 
and expand our model of Adrx activity. Trapping mutants are also effective tools 
to identify redox substrates (Zito et al., 2010b). The mutation of a single cysteine 
allows the mutated protein to enter into redox reactions, forming a mixed disulfide 
with a substrate, but it is unable to terminate the reaction and essentially ‘traps’ 
the two proteins in a covalent bond. However, the mutated protein is never in the 
oxidized form (having only one active cysteine) and thus will only ‘trap’ upstream 
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proteins. Our current model (Figure 5.2) places Adrx as the oxidizing agent, 
upstream of other redox chaperones and unless data inconsistent with this model 
is obtained, we would not expect to catch many substrates.  
 Another area to explore is the influence of Adrx on the mitochondria. The 
ER is now understood to be a dynamic organelle able to communicate with (and 
perhaps originate) lipid droplets and mitochondria. Preliminary data (Tova 
Meshulam) indicate the expression of Adrx directly affects cellular respiration, 
that is, Adrx overexpressing adipocytes consume more O2 and knockdown cells 
consume less. Confocal immunofluorescence shows Adrx almost perfectly 
localized with calnexin, which, while mainly an ER membrane protein, does 
localize to the mitochondrial associated membrane, and there is also a small 
overlap between Adrx and mitochondrial protein porin. (Lynes et al., 2012). While 
Adrx does not have a mitochondrial localization signal, its position in the ER 
membrane might make trafficking or communicating with the mitochondria 
possible. Mitochondria are the main producers of ROS and also require complex 
redox regulation by a variety of thioredoxin fold family proteins.  
Conclusion 
 
We have discovered that Adrx is a key regulator of protein secretion  
In both adipose tissue and pancreatic islets. Secreted proteins have widespread 
influence over many aspects of metabolism, and the dysregulation of secreted 
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proteins during obesity contributes to the metabolic syndrome. Subsequently, the 
expression and activity of Adrx may play a role in mediating alterations in 
systemic metabolism associated with obesity.  
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Figure 5.1 Adrx is a type 2 transmembrane protein with C-terminal active 
site in the lumen of the ER. 
3T3-L1 adipocytes were fractionated into cell surface and internal membranes by 
differential centrifugation as described previously (Simpson et al., 1983). Pellet 
containing light and heavy microsomal fraction was re-suspended in HES buffer 
containing 10% trypsin EDTA (Life Technologies, 15400-054) for 5 minutes at 
room temperature. After 5 minutes, a proportional amount of trypsin inhibitor 
(Sigma, #T0256-1MG) was added for another 5 minutes to quench the reaction. 
Samples were mixed with 10X DTT and 4X Laemmli buffer and run on 12.5% 
SDS-PAGE. Antibodies described in previous chapters as well as anti-FLAG (Cell 
Signaling, Beverly MA). 
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Figure 5.2 Alternative model of oxidative folding incorporating Adrx. 
Simplified model of oxidative folding – Adrx generates a de novo disulfide bond 
utilizing H2O2 as an electron acceptor. Adrx transfers the disulfide to PDI through 
redox exchange chemistry. PDI transfers the disulfide to newly translated 
proteins in the ER. 
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Figure 5.3 ER redox state and oxidized PDI correlate with disulfide bond 
formation and adiponectin secretion. 
(A) 3T3-L1 adipocytes were washed 3x with PBS and treated with 50 uM EN460 
(Millipore, Billerica, MA) an ERo1 inhibitor, or DMSO control for 2 hours in serum 
free DMEM. Media was collected after 4 hours and run on native gels as 
previously described (Chapter 2). (B-D) 3T3-L1 adipocytes were treated with 
DTT, EN460, or vehicle for 30 minutes. DTT chase cells were washed 4x with 
PBS and treated with EN460 or vehicle for an additional 20 minutes. At the end 
of treatment, cells were lysed with 30% TCA in PBS buffer and proteins were 
precipitated with acetone as described (Chapter 2). (B) Quantification of oxidized 
PDI as a percentage of total. (B) Proteins were boiled, run on non-reducing SDS-
PAGE gels and blotted for Adpn or (C) PEGylated and run on SDS-PAGE gels 
and blotted for PDI.  
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